Anti-inflammatory response favouring Leishmania parasite infection (Homo sapiens)

From WikiPathways

Revision as of 18:18, 9 October 2020 by DeSl (Talk | contribs)
Jump to: navigation, search
421413, 24, 4833, 9529, 35, 6046, 51, 947869, 8698922, 68, 8815, 7317, 20, 25, 36, 38...52, 53, 57, 9319, 23, 7216, 26, 44, 8758, 63, 65, 81, 91...11, 37, 46, 61, 943, 1427, 68, 744, 70, 80, 8527, 68, 749010, 844030, 64, 75, 832, 21, 43, 50, 6710, 62, 841, 8, 12, 18, 31...19, 3246, 51, 94458967634, 49, 66, 7128, 41, 54, 56, 82cytosolnucleoplasmendoplasmic reticulum lumenendoplasmic reticulum lumenGolgi lumenMacrophagecytosolT-cellLeishmania parasitenucleoplasmcytosolNAd Ig lambda chain V-VI region AR IGLV4-69(1-?) GNB1 Ig kappa chain V-I region Daudi Zn2+ Ig kappa chain V-III region POM ADCY9 Mg2+ IGHV1-2 VIPR1 FCGR3A ATPIg heavy chain V-I region HG3 TSHB Ig kappa chain V-I region HK101 GLP1R GNG13 LPG1G2 AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramerIGLV(23-?) Ig kappa chain V-III region VG IGLV7-46(1-?) GNG10 Ig heavy chain V-I region EU Ig kappa chain V-I region AU GNAI3 IgG:Leishmaniasurface:p-FCGR3As:p-6Y-SYK:PLCGIGLV3-25(1-?) Ig heavy chain V-I region EU IGHG2 ADAM17YES1 IGLV2-23(1-?) Lma amastigote surface IGKV2-28 ADCY5 IGKC Ig kappa chain V-I region DEE Lma amastigote surface FCGR3A IGKV1-5(23-?) IGLV1-44(1-?) Ig kappa chain V-III region VG IGLV1-44(1-?) Ig lambda chain V-IV region Bau Ig heavy chain V-I region HG3 LTC4:CyslTR1,2GTP HeterotrimericG-protein Gs(inactive)Ig heavy chain V-III region WEA Ig lambda chain V-IV region Bau IGLV10-54(1-?) IGLV3-27(1-?) Ig lambda chain V-III region LOI IGLV2-11(1-?) Ig lambda chain V region 4A ADCY1 IGLV8-61(1-?) Ig lambda chain V region 4A Ig lambda chain V-I region HA ADCY5 Ig heavy chain V-II region ARH-77 PRKACG Ig heavy chain V-III region TRO DRD5 GTP PRKACG p-T180,Y182-MAPK14 Ig heavy chain V-III region CAM Ig lambda chain V-I region NEWM Ig kappa chain V-I region BAN LTC4IGHG2 IGKC PGD2 Ig lambda chain V region 4A PGI2 Ig kappa chain V-II region RPMI 6410 GNB4 IGLV3-22(1-?) IGLV4-60(1-?) Ig lambda chain V-I region NEWM IGLV7-43(1-?) PRKACA,(PRKACB,PRKACG,PRKX)IGKV4-1(21-?) IGLV2-33(1-?) IGLV7-43(1-?) IgG:Lmaantigens:FCGR3A:CD3dimersPRKACA IGLV1-44(1-?) DRD1 GNG4 IGLC3 GNAS1 IgH heavy chain V-III region VH26 precursor iRHOM2IGHV1-2 IGLV3-22(1-?) IGLV7-46(1-?) IGHV7-81(1-?) PRKAR1A Ig heavy chain V-II region NEWM GNG4 IGLV8-61(1-?) Ig kappa chain V-I region Gal p-Y753,Y759,Y1217-PLCG2 Ig lambda chain V-II region NEI ADCY5 Ig heavy chain V-II region OU LPG1G2ADCY8 Ade-Rib PRKACB IGLV8-61(1-?) Ig kappa chain V-I region Gal IGLV2-11(1-?) IGLC3 IGKV4-1(21-?) IAPP(34-70) GNB5 GNB2 LPG1G2 IGKVA18(21-?) Ig lambda chain V-I region NEW IGLV11-55(1-?) IGLV3-27(1-?) GNGT1 CALCB(82-118) IGHV1-2 IGKV2D-30 Ig kappa chain V-I region DEE LPG1G2 IGHG3 ADCY3 p-4Y-PLCG1 Ig kappa chain V-I region BAN ADCY2 GNB1 Ig kappa chain V-II region Cum Ig lambda chain V-III region SH Ig kappa chain V-II region RPMI 6410 IGHG1 IGKV3D-20 Ig lambda chain V-III region SH Ig heavy chain V-II region ARH-77 Ig lambda chain V-IV region Bau IGKV3D-20 Ig lambda chain V-III region SH IGLV3-16(1-?) Ig kappa chain V-II region FR IGLV3-22(1-?) Ig lambda chain V-IV region Hil GGT1(381-569) ADRB3 Ig kappa chain V-III region VG Ig heavy chain V-III region TRO Ig heavy chain V-III region DOB Ig kappa chain V-I region HK101 IGLV5-45(1-?) Ig heavy chain V-III region DOB IGHG4 p-6Y-CD247 IGLV7-46(1-?) SCTR IGLV4-60(1-?) Ig lambda chain V-II region MGC Ig heavy chain V-III region BUT GNG8 IGLV8-61(1-?) Ig heavy chain V-III region JON Ig lambda chain V-II region BOH IGLV3-27(1-?) IGHV7-81(1-?) PLK2, MAPK14cAMP:PKA regulatorysubunitIg heavy chain V-III region CAM IGLV5-45(1-?) Ig lambda chain V-III region LOI Ig heavy chain V-I region HG3 ADCY1 GNG11 GNG2 GPHA2 PTH2(62-100) GIPR GNG5 IGLV2-11(1-?) IGLV2-18(1-?) Ig lambda chain V-II region MGC IGLV5-37(1-?) Ig heavy chain V-I region EU IGLV3-22(1-?) Ig heavy chain V-II region WAH Ig kappa chain V-III region B6 Ig lambda chain V-I region NEW IGHG1 Ig kappa chain V-II region FR Ig lambda chain V-II region BOH IGHV(1-?) Ig lambda chain V-IV region Bau IGLV7-43(1-?) IGLV5-45(1-?) Ig kappa chain V-I region Wes IGLV(23-?) IGHV(1-?) Ig lambda chain V-VI region AR Ligand:GPCRcomplexes thatactivateGs:HeterotrimericG-protein Gs(inactive)Ig heavy chain V-II region NEWM IGHV7-81(1-?) IGKV1-5(23-?) p-Y160,Y171-CD3G GNB3 PRKAR1B Ig lambda chain V-I region NEW GNG2 IGHG1 ADCY2 Ig lambda chain V-II region MGC IGLC7 IGLC1 MC5R p-S133-CREB1:IL6geneADCY9 p-S133-CREB1 Ig kappa chain V region EV15 GNG2 LPG1G2 IGLC7 Ig lambda chain V-IV region Hil Ig kappa chain V-I region BAN IGLV(23-?) Ig heavy chain V-III region WEA ADAM17(215-827)IGLC2 IGLV7-46(1-?) Ig lambda chain V-IV region Kern Ig heavy chain V-III region TRO IGLC2 IGLV3-22(1-?) IGKV3D-20 Ig kappa chain V-I region DEE Ig lambda chain V-I region HA Ig heavy chain V-II region OU Ig heavy chain V-II region MCE Ig lambda chain V-II region TOG GIP(52-93) Ig lambda chain V-III region LOI IGLV11-55(1-?) IGLV7-46(1-?) IGLV11-55(1-?) Ig heavy chain V-II region WAH CRHR1 Ig lambda chain V-IV region Hil p-S133-CREB1:IL10geneIGKC Ig lambda chain V-II region NEI GGT1(1-380) Ig kappa chain V-III region POM GNG8 CYSLTR2 Ig lambda chain V-I region HA TAAR2 Ig lambda chain V-III region LOI Ig heavy chain V-III region KOL IGLV2-11(1-?) GNAS1 Ig lambda chain V-I region NEW Ig kappa chain V-III region POM DPEP1,2,3 dimersMYH9 Ig lambda chain V-III region SH GNB5 IGLV2-18(1-?) ADCYAP1(132-169) Ig heavy chain V-III region TRO IGKV1-5(23-?) PLCG1 IGLV2-11(1-?) Ig heavy chain V-II region MCE IGLV5-37(1-?) Ig heavy chain V-III region BRO IGLC1 Ig kappa chain V-I region AG IGKV2-28 IGKC NPS IGHG1 Ade-Rib Ig lambda chain V-IV region Kern GNB3 Ig heavy chain V-III region WEA DCA Ig heavy chain V-I region HG3 IGLV2-23(1-?) Ig kappa chain V-III region VG IGLC1 PRKAR1A PRKAR2A GGT5(388-586) Ig lambda chain V-I region HA Ig heavy chain V-III region CAM Ig kappa chain V-I region BAN Ig heavy chain V-II region MCE GDP IGHG4 GNB5 ADCY2 Ig kappa chain V-I region Gal IGKV2-28 IGLV1-44(1-?) IGHG2 Ig kappa chain V-I region HK101 Ig heavy chain V-III region WEA IGKV2-28 ADCY7 ADAM17(215-827):Zn2+IGLC7 Ig heavy chain V-I region HG3 ADCY4 GNG3 ADCY8 MC3R(1-360) IGKV3D-20 Ig kappa chain V-I region Wes Ig kappa chain V-II region RPMI 6410 IGHV7-81(1-?) IGLV1-36(1-?) GGT1 dimerIGHG2 Ig heavy chain V-III region DOB GNGT2 Ig heavy chain V-II region OU IGLV10-54(1-?) PLCG2 Ig lambda chain V-II region TOG IGKV2-28 IGHV1-2 IGKV3D-20 GDPIg kappa chain V-III region POM Ig lambda chain V-IV region Kern IGLV5-37(1-?) Ig kappa chain V-II region RPMI 6410 Ade-Rib p-6Y-SYK CDCA GNB2 IGLV1-44(1-?) Ig lambda chain V-IV region Hil Ig heavy chain V-II region ARH-77 Ig lambda chain V-I region NEW GNAS1 Zn2+ Ig lambda chain V-IV region Bau Ig heavy chain V-II region OU IGHV1-2 GGT1(381-569) Ig kappa chain V-II region RPMI 6410 Zn2+ Ig kappa chain V-I region AG Ig kappa chain V-I region AG ADCY4 TAAR1 Ig heavy chain V-II region WAH ITPR2 Ig heavy chain V-II region WAH IGLV2-11(1-?) IGLV5-45(1-?) PRKACG Ig lambda chain V-III region LOI Ig kappa chain V-I region AU Ig kappa chain V-III region B6 IGLV1-36(1-?) IGLV3-12(1-?) Ig lambda chain V-I region HA GNG4 IGHG1 IGLV5-45(1-?) IGKV2-28 Ig heavy chain V-II region WAH Ig kappa chain V-I region BAN Ig lambda chain V-II region BOH IGLV4-60(1-?) IGLV3-25(1-?) IGHG4 IGLV10-54(1-?) LTE4Ig kappa chain V-III region B6 Ig lambda chain V-I region NEW Ig kappa chain V region EV15 IGLC7 TAAR8 GlyIg kappa chain V-I region Daudi Ig heavy chain V-III region BUT IGLV5-45(1-?) GNB2 CYSLTR1,CYSLTR2IGLV7-46(1-?) IL6 gene IGKV1-12 Ig heavy chain V-III region WEA IGLV2-11(1-?) IGLV10-54(1-?) Ig heavy chain V-III region WEA Ig lambda chain V-VI region AR IGLC6 Ig lambda chain V-VI region AR Ig lambda chain V-IV region Kern PRKAR1B IGHV1-2 IGLV5-37(1-?) Glucocorticoid, IL6,IL10GNG2 Ig kappa chain V-II region FR IGHG1 Ig kappa chain V-II region Cum Ig lambda chain V-II region TOG Ig lambda chain V-I region HA IGLV1-40(1-?) Ig kappa chain V-III region VG IGLV2-11(1-?) IGKC Mg2+ Ig lambda chain V-III region LOI IGHG1 GNGT1 Ig lambda chain V-IV region Bau Ig lambda chain V-IV region Kern p-6Y-SYK IGLC7 GNG10 IGLC2 PTH2R Ig lambda chain V-III region SH Ig lambda chain V-I region NEWM Ig kappa chain V-I region DEE IGLV3-25(1-?) Ig lambda chain V-II region MGC IGHG4 IGLC2 IGLC1 IGLV2-33(1-?) IGLV1-36(1-?) GNG10 glucocorticoid ADCY4 FGR CD3G ADRB2 IGKV1-12 Ig kappa chain V-I region Daudi Ig lambda chain V-II region NEI IGKV1-12 Ig lambda chain V-I region VOR Ig kappa chain V-I region Wes IGLV3-16(1-?) L-GluADAM17(215-827) IGLV5-45(1-?) IGKVA18(21-?) POMC(138-176) G-betagammaGNG3 HRH2 Ig kappa chain V-II region Cum IGLV5-37(1-?) IGHG3 ADCY5 p-Y288,Y304-FCGR2A ADORA2B CYSLTR1 IGLV5-37(1-?) LTD4GNAT3 Ig heavy chain V-II region WAH Ig heavy chain V-III region KOL IGHG2 Ig kappa chain V-I region Wes IGLC2 IgG:Lma antigensCD163(1051-1156)POMC(77-87) IGHV7-81(1-?) IGLC6 Ig heavy chain V-II region NEWM IGLV2-33(1-?) GNGT2 Ig heavy chain V-III region KOL GNB1 IGHV1-2 Lma amastigote surface Ig lambda chain V-I region NEWM IGLV4-3(1-?) IGLC1 Ig lambda chain V-IV region Bau p-PLCGIGLC1 ADCYAP1(82-129) Ig heavy chain V-II region MCE p-S133-CREB1 IGLV7-46(1-?) Ig kappa chain V-I region AG DPEP2 Ig heavy chain V-III region TRO Ig kappa chain V-I region BAN 5HT GPHB5 TAAR6 Ig lambda chain V-I region NEW Ig heavy chain V-II region NEWM NAD+ p-6Y-SYK IGLV3-12(1-?) Ig lambda chain V-II region BOH IGHV(1-?) IGLV10-54(1-?) GNG8 IGLV2-18(1-?) IGKV2-28 Ig heavy chain V-III region BUT Ig heavy chain V-II region NEWM IGHV7-81(1-?) IGLC3 Ig heavy chain V-III region JON Ig kappa chain V-II region RPMI 6410 IGKV2D-30 Ig kappa chain V-II region Cum IGLV5-45(1-?) Ig heavy chain V-III region BUT TAAR3 IGHG3 IGLV1-44(1-?) GNAZ IGHG4 IGLV4-3(1-?) INSL3(106-131) Ig kappa chain V-I region Wes IGHG1 CCA Ig heavy chain V-I region EU Ig lambda chain V region 4A Ig lambda chain V-II region NEI Ig heavy chain V-III region DOB IGLV11-55(1-?) Ig kappa chain V-II region Cum CYSLTR2 Ig heavy chain V-II region MCE Ig lambda chain V-IV region Kern Ig lambda chain V-I region NEW Ig kappa chain V-I region AG PLCG2 I(1,4,5)P3 Ig heavy chain V-III region BUT IGLC2 IGLV5-37(1-?) Ig kappa chain V region EV15 Ig lambda chain V-I region NEWM Ig kappa chain V-I region Wes Ig heavy chain V-III region BUT ADCY6 ArgN-GCG(98-127) IGLC1 Ig lambda chain V-II region NEI ADR Ig kappa chain V-II region Cum ATPIg heavy chain V-I region EU Ig kappa chain V-II region Cum Lma amastigote surface Ig heavy chain V-II region WAH Ig lambda chain V-I region VOR CD3G PLCG1 IGKV3D-20 RLN2(25-53) Ig heavy chain V-III region BUT Ig lambda chain V-IV region Hil IGLC3 Ig heavy chain V-III region TRO CD247-1 Ig heavy chain V-III region BRO Ig kappa chain V-III region VG ADCY4 G alpha(s):GTP:AdenylatecyclaseIGLV4-69(1-?) IGLV8-61(1-?) Ig lambda chain V-I region NEWM Ig kappa chain V-I region Gal IGKV1-5(23-?) GNG8 IGHV1-2 Ig kappa chain V region EV15 ADCY1 GGT5(1-387) ADCY4 IGLV7-43(1-?) Ig heavy chain V-I region EU p-Y160,Y171-CD3G IGLV2-23(1-?) IGLC1 Ig heavy chain V-II region OU GNGT1 IGKV2D-30 Adenylate cyclase(Mg2+ cofactor)IgH heavy chain V-III region VH26 precursor Ig kappa chain V-I region AG IGKV2D-30 Ig lambda chain V-VI region AR GCG(53-81) Ig heavy chain V-III region BRO ATP GNAS1 GNAI1 IGLV1-36(1-?) GNG7 IGLV11-55(1-?) PRKACA PI(3,4,5)P3 GNG13 IGLC2 Ig kappa chain V-II region RPMI 6410 Ig heavy chain V-III region BRO GNG7 Ig heavy chain V-III region CAM Ig kappa chain V region EV15 IGLV4-69(1-?) Ig lambda chain V-I region NEW Ig kappa chain V-I region Wes IGLV3-16(1-?) IGLV5-45(1-?) Ig lambda chain V-II region BOH IGLV11-55(1-?) IGLV3-16(1-?) Ig kappa chain V-I region AG IGKVA18(21-?) IGLV1-44(1-?) PRKAR1B Ig heavy chain V-II region OU Ig kappa chain V-III region VG RAMP2 Ig heavy chain V-I region EU RAMP3 Ig heavy chain V-II region MCE IGLV8-61(1-?) IGLV4-3(1-?) Ig kappa chain V-I region HK101 ITPR1 IgH heavy chain V-III region VH26 precursor ADPIGKV1-12 IGKC ATPPRKACB GNG12 Ig heavy chain V-III region JON Ig heavy chain V-III region KOL IGLV3-22(1-?) IGKV3D-20 IGLV7-43(1-?) GNB4 Ig lambda chain V-I region HA Ig kappa chain V-I region Wes Ig lambda chain V-VI region AR IGKC IGKVA18(21-?) GNG2 cAMP Ig lambda chain V-III region LOI IGLC6 ADAM17(215-827) Ig heavy chain V-II region NEWM Ig kappa chain V-I region AU GNG10 ADCY2 Ig lambda chain V-II region BOH Ig heavy chain V-III region DOB IGLC6 IGLV8-61(1-?) IGLV7-46(1-?) IGLV4-60(1-?) G-protein beta-gammacomplexIGKV2-28 IGHV(1-?) GNG5 IGKV4-1(21-?) IGLV3-27(1-?) PRKAR2A Ig lambda chain V-III region LOI IGLV1-40(1-?) Ig lambda chain V-II region NEI IGLV4-69(1-?) GNGT2 Ig kappa chain V-III region VG ADCY8 ADCY6 Ig heavy chain V-III region WEA IGLV1-40(1-?) TAAR5 IgG:Leishmaniasurface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCGIGLC6 Ig kappa chain V-I region HK101 LYN IGLV3-25(1-?) IGKV4-1(21-?) IGLV1-40(1-?) Ig lambda chain V-II region NEI Ig kappa chain V-III region B6 P2RY11 Ig kappa chain V-III region POM IL10TSHR PTGDR IGLV11-55(1-?) IgG:Lmaantigens:FCGR3A:p-CD3 dimersADORA2B IGKV3D-20 Ig kappa chain V-I region AG GNG12 CALM1:4xCa2+FYN IGHG4 Ig heavy chain V-II region NEWM Ig kappa chain V-III region VG IGLV4-60(1-?) Ig heavy chain V-III region KOL CRH Ig kappa chain V-III region VG IGHG2 IGLV3-25(1-?) Ig kappa chain V-II region Cum IGLV4-69(1-?) Ig kappa chain V-III region B6 IGLV2-18(1-?) IL6 geneDPEP3 GNB4 IGLV3-12(1-?) IGLV(23-?) GNG3 IGLV2-11(1-?) CALM1 Ade-Rib IGHV1-2 Ig lambda chain V-II region BOH IGHV(1-?) IGLV3-16(1-?) IGLV3-16(1-?) Ig kappa chain V-I region AU IGLV3-12(1-?) IGKVA18(21-?) Lma amastigote surface FCGRIIIA:CD3G/CD3ZdimersIGLV4-3(1-?) p-6Y-CD247 GNB1 Ig lambda chain V-II region MGC p-6Y-CD247 p-4Y-PLCG1 IGLV5-37(1-?) IGKV2-28 IGKV2D-30 GNB3 CYSLTR1 FURINIg kappa chain V-I region BAN Ig heavy chain V-III region TRO IGKV2D-30 IGLV11-55(1-?) Ig heavy chain V-II region ARH-77 IGLC1 Ig lambda chain V region 4A Ig lambda chain V-II region TOG Ig kappa chain V-I region DEE FCGR3A Ig heavy chain V-I region HG3 Ig kappa chain V-I region BAN IGLV4-60(1-?) GNB2 PKA tetramerIGKV4-1(21-?) Ig lambda chain V-III region SH PRKAR2B IGKV2-28 IGLV2-11(1-?) PTGER4 ADCY3 IGLV3-25(1-?) IGKV3D-20 IGLV7-43(1-?) Ig lambda chain V-IV region Bau PRKACA IGLC3 CALCA(83-119) GTP Ig lambda chain V-II region NEI Ig kappa chain V-III region POM Ig heavy chain V-III region JON Ig heavy chain V-II region NEWM Ig kappa chain V-I region AU IGHV7-81(1-?) H2OFCGR3A IGHV(1-?) IGHG4 Zn2+IGHG2 Ig heavy chain V-III region CAM IGLV1-40(1-?) Ig kappa chain V-I region HK101 GNB3 GNAS2 Ig lambda chain V-IV region Hil IGLC6 G-protein alpha(i):GTP:AdenylatecyclaseIg kappa chain V region EV15 IGKVA18(21-?) IGLC7 IGLV8-61(1-?) IGHV(1-?) Ig kappa chain V-I region BAN cAMP IGLV4-3(1-?) IgG:Lma amastigotesurfaceIg kappa chain V-II region FR IGLV(23-?) GNGT2 IGLV4-3(1-?) LPG1G2 IGHG3 PRKAR2B Ig heavy chain V-III region JON Ig lambda chain V-II region MGC IGLV3-12(1-?) IGLV3-22(1-?) Constitutively active orphan GPCRs IGLV2-23(1-?) IGLV7-46(1-?) Ig kappa chain V-I region DEE GPBAR1 PLCG2 RXFP1 ITPR1 GNG4 Ig heavy chain V-III region JON ADCY5 ADORA2A Ig kappa chain V-III region POM Ig kappa chain V-II region RPMI 6410 IGHG3 Ig lambda chain V-IV region Hil GNGT2 IGLV(23-?) Ig kappa chain V-II region RPMI 6410 IL10 IGLV4-69(1-?) IGLV10-54(1-?) Ig lambda chain V region 4A ITPR3 PKA tetramer:4xcAMPIGLV10-54(1-?) G alpha (s):GTPGNG12 Ig heavy chain V-III region CAM Ig lambda chain V-II region NEI Ig kappa chain V-I region HK101 IGLC3 IGLV3-12(1-?) IGLC7 Ig heavy chain V-II region WAH Ig heavy chain V-III region DOB Ig lambda chain V region 4A SCT IGLV1-40(1-?) FCGR1A IGKV2D-30 IGLV2-33(1-?) CD163PPiGNG10 Ig heavy chain V-III region BUT ADCY7 GNG13 LPG1G2 IGLV3-12(1-?) GGT1(1-380) GNAI2 DAGsIg heavy chain V-II region OU PRKACG IGLV4-3(1-?) Ig kappa chain V-II region RPMI 6410 IGLV3-16(1-?) IGLV3-25(1-?) GNAS2 IgH heavy chain V-III region VH26 precursor PLCG1 IGLV7-43(1-?) ITPR2 IGLV7-43(1-?) GLP-1 (7-37) Ig heavy chain V-II region NEWM Ig lambda chain V-I region HA IGLV1-40(1-?) Ig lambda chain V-I region VOR Ig lambda chain V-II region BOH ADCY8 FCGR3A Ig lambda chain V-I region VOR IGKV1-12 Ig lambda chain V-II region BOH IGKV2D-30 IGLV11-55(1-?) Ig lambda chain V-IV region Hil IGHG3 IGLV2-33(1-?) Mg2+ Ig kappa chain V-I region Daudi Ig lambda chain V-II region MGC IGHV(1-?) IGLV3-27(1-?) IgH heavy chain V-III region VH26 precursor IGKV1-5(23-?) IGLV3-22(1-?) Ig heavy chain V-II region MCE ADCY8 MC1R Ig lambda chain V-III region SH IGLV4-3(1-?) Ig heavy chain V-III region DOB Ig kappa chain V-II region FR Ig kappa chain V-I region HK101 IGLV1-36(1-?) IgG:LPG1G2IGLV2-23(1-?) IGHV(1-?) IGKVA18(21-?) IGLV4-60(1-?) Ig lambda chain V-IV region Kern sCD163PRKACA Ig heavy chain V-III region KOL Ig lambda chain V-IV region Hil Ig kappa chain V-I region DEE Ig heavy chain V-III region JON IGLV7-43(1-?) SYKPI(4,5)P2Ig lambda chain V-II region BOH IGLV3-25(1-?) IGLV3-25(1-?) Ig heavy chain V-III region BRO GNG12 RAMP1 IGLV(23-?) Ig lambda chain V-I region VOR FCGR3A GNAS2 AVP(20-28) Ig heavy chain V-III region KOL IGLV1-44(1-?) IgH heavy chain V-III region VH26 precursor IGHG2 IGHG1 CALCRL IGLV4-69(1-?) Ig lambda chain V-III region SH PKA catalyticsubunitIg kappa chain V-I region Wes Ig lambda chain V-II region MGC CALCA(83-119) GNG5 PRKACB Ig kappa chain V-I region Gal Ig lambda chain V-II region MGC Adenylate cyclase(Mg2+ cofactor)Ig lambda chain V-II region NEI IGKV1-12 IGLC2 IGKV4-1(21-?) Ig kappa chain V region EV15 Ig heavy chain V-II region ARH-77 PRKX Ig lambda chain V-I region VOR Ig heavy chain V-III region BRO Ig kappa chain V-III region VG LHB POMC(138-150) Ig kappa chain V-I region AU Ig lambda chain V-II region TOG ADCY7 ITPR3 ADCY3 IGLV3-25(1-?) Ig heavy chain V-I region HG3 ADCY2 Ig kappa chain V-II region FR IGHG2 Ig heavy chain V-II region OU PTH IGLC7 GNB5 Ig lambda chain V-I region NEWM IGLV4-3(1-?) Ca2+IGLV7-43(1-?) GNAS2 Ig kappa chain V-I region Daudi Lma amastigote surface IgGIGLV3-22(1-?) Ig kappa chain V region EV15 Ig heavy chain V-I region HG3 Ig lambda chain V-I region VOR CALCR Ig heavy chain V-III region CAM IGLV3-27(1-?) ITPR1 IGKV2D-30 Ig kappa chain V-I region AU IL10 geneIGLV5-37(1-?) GNGT1 Ig kappa chain V-I region DEE CREB1IGLV1-36(1-?) Ig kappa chain V-III region B6 ATPIg kappa chain V-I region BAN ADCY7 LPG1G2 ITPR2 ADAM17(215-827):Zn2+IGLC2 Ig kappa chain V-II region FR Ig heavy chain V-II region MCE IGLV2-33(1-?) Ig lambda chain V-III region LOI ADORA2B:Ade-RibIGKV2D-30 IGLV1-44(1-?) HTR6 Ig heavy chain V-II region MCE Ig kappa chain V region EV15 ADCY6 sCD163Ig kappa chain V-II region Cum Ig heavy chain V-III region BRO Ig heavy chain V-III region BUT IGLC3 Ig kappa chain V-I region Gal GNGT1 Ig heavy chain V-II region NEWM Ca2+Ig kappa chain V-I region DEE Ig heavy chain V-II region WAH IGKVA18(21-?) IGLV5-45(1-?) p-Y753,Y759,Y1217-PLCG2 Ig lambda chain V-I region HA IP3 receptorhomotetramerIGLV(23-?) IGLV1-36(1-?) RXFP2 IGLV4-60(1-?) I(1,4,5)P3IGHV(1-?) INSL3(21-55) IGHV1-2 Ig lambda chain V-I region VOR Ig heavy chain V-III region WEA Ig lambda chain V-II region MGC Zn2+ Ig lambda chain V-IV region Kern IGLV3-27(1-?) IGLV10-54(1-?) IGHV7-81(1-?) Ig lambda chain V-II region MGC NPSR1 GNG8 IGLC7 IGLV2-18(1-?) Ig lambda chain V-IV region Kern H2OH2OIg heavy chain V-III region TRO p-Y160,Y171-CD3G GHRH IGLV3-12(1-?) Ig heavy chain V-III region CAM ADCY9 Ig lambda chain V-II region TOG Ig lambda chain V-I region NEWM Mg2+ Src family kinases(SFKs)IGKV1-5(23-?) IGLV5-37(1-?) IGLV2-33(1-?) IGLC7 IGLC6 LCHA Ig kappa chain V-I region Gal Ig kappa chain V-I region AG IGLC2 ADAM17IGLC6 p-S,T-ADAM17(215-827):Zn2+Ig lambda chain V-I region NEW IGLC3 GNG7 Ig heavy chain V-III region TRO IGLV3-25(1-?) IGKC GTP GNG13 IgH heavy chain V-III region VH26 precursor IGLV2-23(1-?) I(1,4,5)P3 Ig kappa chain V-I region HK101 Ig kappa chain V-I region DEE Ig heavy chain V-III region JON Ig kappa chain V-I region Gal ADCY3 IGLV2-23(1-?) IgH heavy chain V-III region VH26 precursor Ig heavy chain V-II region OU Ig heavy chain V-III region JON GNG3 GNG5 Ig lambda chain V region 4A GNB5 Ig kappa chain V-I region Gal Ig heavy chain V-III region KOL Ig heavy chain V-I region EU IGHG1 p-Y160,Y171-CD3G Ig heavy chain V-II region ARH-77 IGLV2-18(1-?) PRKACB IGKV4-1(21-?) ATPIGHG3 GPR39 IGLV(23-?) IGLV4-69(1-?) Ig lambda chain V-VI region AR Ig heavy chain V-III region KOL IGLC3 Ig lambda chain V-III region LOI GDP GNAS1 GNAS2 Lma amastigote surface Ig lambda chain V-II region NEI Ig lambda chain V-I region VOR IGKV4-1(21-?) Ig kappa chain V-I region Daudi Ig kappa chain V-I region AU Ig heavy chain V-II region ARH-77 IGLV2-33(1-?) IGHV7-81(1-?) IGLV7-46(1-?) Ig kappa chain V-I region AG IgH heavy chain V-III region VH26 precursor IL6CD247-1 Ig lambda chain V-II region TOG ADCY7 GNG4 GNG11 PTH1R ADCY6 Ig lambda chain V-IV region Bau Ig lambda chain V-III region SH IGLV1-36(1-?) IGLV1-36(1-?) Ig kappa chain V-II region FR IGKV4-1(21-?) Ig kappa chain V-I region Daudi Ig heavy chain V-III region BUT GNB4 PTGER2 IGKV2D-30 Ig kappa chain V-III region B6 IGKC IGLV3-27(1-?) ATPp-6Y-SYK Ig lambda chain V-II region TOG IGKVA18(21-?) Ig kappa chain V-II region FR Ig heavy chain V-III region CAM Ig kappa chain V-I region Gal Ig heavy chain V-III region WEA IGHG3 AHCYL1 IGLV4-69(1-?) PEA Ig kappa chain V-II region FR sCD163:MYH9IGHG4 Ig kappa chain V-III region B6 Ig kappa chain V-III region POM PRKACA GCG(146-178) IGLV4-60(1-?) Ig lambda chain V-II region TOG Ig lambda chain V-IV region Kern Ig heavy chain V-II region NEWM IGLV(23-?) LPG1G2 Ig kappa chain V-I region HK101 Ig lambda chain V-I region VOR IGLV1-44(1-?) IGLC6 IGKV1-12 Ig heavy chain V-III region BUT Zn2+ PRKAR1A Mg2+ IGLV5-37(1-?) Ig lambda chain V-III region LOI AVPR2 Ig heavy chain V-III region BRO IGLV2-18(1-?) Ig heavy chain V-II region ARH-77 Ig kappa chain V-II region Cum IGLV7-46(1-?) IGLC7 Ig lambda chain V-VI region AR IgH heavy chain V-III region VH26 precursor Ig lambda chain V-II region TOG Ig heavy chain V-III region BRO ADCY1 Hist IGLV3-16(1-?) Ig heavy chain V-I region HG3 IGKV1-5(23-?) Ig lambda chain V-I region HA IGLV4-3(1-?) ATPProtein Kinase A,catalytic subunitsIGKVA18(21-?) IGLC3 Ig kappa chain V region EV15 IGLV2-18(1-?) Ig lambda chain V-II region BOH IGLV1-40(1-?) IGLV2-23(1-?) GNG7 Ig lambda chain V region 4A IGLV8-61(1-?) CRHR2 Ig lambda chain V-I region VOR IGHG4 IGLV3-16(1-?) Ig kappa chain V-II region FR DA Ig heavy chain V-III region BRO IGKC Antigen GTP HTR4 Ig heavy chain V-III region TRO Ig heavy chain V-II region MCE Ig kappa chain V-II region RPMI 6410 IGLV2-18(1-?) IGHV7-81(1-?) IgG:Lmaantigens:FCGR3A:p-CD3 dimers:SYKIg kappa chain V-I region Gal Ig heavy chain V-I region HG3 IGHV7-81(1-?) Ig kappa chain V-III region POM GLP2R PRKAR2A Ig heavy chain V-II region ARH-77 IGHG4 IGLV1-40(1-?) ADPIGHV(1-?) IGLV2-33(1-?) CYSLTR2 IGLV10-54(1-?) Ig heavy chain V-III region DOB Ig lambda chain V-III region SH GNB1 ADORA2B Ig heavy chain V-III region DOB IGLV10-54(1-?) VIP(125-152) Ig heavy chain V-I region EU MC4R GNAS2 Ig lambda chain V-IV region Kern Ig heavy chain V-II region ARH-77 clusteredIgG-Ag:p-FCGRs:p-6Y-SYK:PLCGIg lambda chain V-III region SH Ig heavy chain V-III region DOB GNG7 Ca2+ TAAR9 IGLV2-33(1-?) ADPIg lambda chain V-VI region AR CALM1PRKACB LTC4 VIPR2 FSHR Ig kappa chain V-I region Wes MYH9PTGIR p-6Y-CD247 Ig heavy chain V-I region EU IGLV2-18(1-?) IGLV3-16(1-?) CD163 geneIGLV3-27(1-?) ADM2(19-153) Ig kappa chain V-I region Daudi IGLV1-40(1-?) Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDPIGLV3-12(1-?) Ig heavy chain V-II region OU RLN2(162-185) IGLV1-44(1-?) Ig kappa chain V-II region Cum ADCYAP1(132-158) IGLV1-36(1-?) Ig kappa chain V-III region POM Ig heavy chain V-III region CAM Ig lambda chain V-I region HA GDP IgG:Lmaantigens:FCGR3A:p-CD3 dimers:p-6Y-SYKPI(3,4,5)P3IGLV3-12(1-?) POMC(217-234) Ig kappa chain V-I region Daudi Ig heavy chain V-II region WAH IGLC2 Ig heavy chain V-II region ARH-77 PLC gamma1,2IGLV4-69(1-?) GNG13 Ig heavy chain V-III region JON IGLV2-23(1-?) ADORA2BADAM17(1-214)IL10 gene p-S133-CREB1ADORA2B GGT1, 5 dimersSRC-1 IGLV2-33(1-?) Ig lambda chain V-I region NEW Ig lambda chain V-VI region AR p-6Y-CD247 IGLV1-36(1-?) IGLV3-27(1-?) Ig kappa chain V region EV15 IGKV1-12 Ig lambda chain V-IV region Bau p-6Y-CD247 Ig heavy chain V-III region JON IGLV4-3(1-?) Ig heavy chain V-III region BRO Ig kappa chain V-I region HK101 IGHG1 IGHG3 IGHV1-2 IGKV3D-20 HCK Ig heavy chain V-III region TRO Ig kappa chain V-I region AG Ig kappa chain V-I region Daudi Ig kappa chain V-III region B6 Ig lambda chain V-I region NEWM iRHOM2IGLV4-60(1-?) Ig heavy chain V-III region KOL IGKV1-5(23-?) Lma amastigotesurfaceIGKV1-5(23-?) PLK2 IGKV4-1(21-?) IGHG2 IGLC1 IL6 Ig kappa chain V-I region AU Zn2+ sCD163 ADCY9 G-protein alpha(z):GTP:AdenylatecyclaseIgH heavy chain V-III region VH26 precursor ADCY3 RLN3(119-142) Ig lambda chain V-IV region Bau ADM(95-146) Ig heavy chain V-III region WEA Ig kappa chain V-I region AU IGLV8-61(1-?) ADCY9 PRKAR2B IGKV2-28 DPEP1 IGLV3-22(1-?) Ig lambda chain V region 4A IGLV4-69(1-?) RLN3(26-52) IGKV1-12 Ig lambda chain V-I region NEWM ADCYAP1R1 IGKV3D-20 ADPGNG3 IGLC6 Ig heavy chain V-III region DOB IGLV2-23(1-?) SYK PTHLH IGLV11-55(1-?) ADPIg lambda chain V region 4A IGLV3-27(1-?) PGE2 cAMPIGLV2-11(1-?) IGLV3-16(1-?) Ig heavy chain V-I region HG3 IGKVA18(21-?) Ig heavy chain V-II region OU ADCY1 Ig heavy chain V-III region CAM Ig kappa chain V-III region B6 IGLC1 IGLV2-23(1-?) GNG11 IGLV1-40(1-?) Ig heavy chain V-III region WEA MC2R Ig kappa chain V-III region B6 IGLV11-55(1-?) IGLC3 FCGR3A IGHG2 IGKV1-12 GNG11 Ig lambda chain V-II region TOG IGLV5-45(1-?) GNG12 GNAS1 IGLV7-43(1-?) IGLC6 Ig heavy chain V-II region WAH PRKACG Ig lambda chain V-I region NEWM Lma amastigote surface IGLV(23-?) ITPR3 Ade-Ribp-Y160,Y171-CD3G Ig kappa chain V-I region AU GNG5 CGA Ig kappa chain V-III region POM IGKV4-1(21-?) GNB3 IGKV1-12 IGLV3-22(1-?) ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTPp-Y160,Y171-CD3G FCGR3A IGHG3 ADRB1 IGLV4-60(1-?) Ig kappa chain V-I region Daudi GNB4 IGKV1-5(23-?) Ig heavy chain V-II region MCE Ig lambda chain V-VI region AR IGKC Ig kappa chain V-I region Wes ADCY6 IGLV10-54(1-?) IGLV8-61(1-?) LHCGR FSHB Ig lambda chain V-IV region Hil GNB2 Ig kappa chain V-I region BAN IGKV1-5(23-?) Ig lambda chain V-IV region Hil GNG11 HTR7 ITPR:I(1,4,5)P3tetramerIGLV2-18(1-?) Ig heavy chain V-III region KOL IGHG4 GHRHR Ig kappa chain V-I region DEE ADAM17(215-827) IGLV3-12(1-?) PPiIg heavy chain V-I region EU IGHG3 GTP3955975555755, 627


Description

Macrophages specializing in tissue repair or associated with a Th2-type immune response are more permissive to infection with leishmania, since their defense mechanisms are not very efficient in eliminating the parasite and can contribute to its persistence (Lee et al. 2018). View original pathway at Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 9662851
Reactome-version 
Reactome version: 74
Reactome Author 
Reactome Author: Jassal, Bijay

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Buxbaum LU.; ''Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.''; PubMed Europe PMC Scholia
  2. Simpson RE, Ciruela A, Cooper DM.; ''The role of calmodulin recruitment in Ca2+ stimulation of adenylyl cyclase type 8.''; PubMed Europe PMC Scholia
  3. Zhang JY, Nawoschik S, Kowal D, Smith D, Spangler T, Ochalski R, Schechter L, Dunlop J.; ''Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.''; PubMed Europe PMC Scholia
  4. Asadullah K, Sterry W, Volk HD.; ''Interleukin-10 therapy--review of a new approach.''; PubMed Europe PMC Scholia
  5. Sanin DE, Prendergast CT, Mountford AP.; ''IL-10 Production in Macrophages Is Regulated by a TLR-Driven CREB-Mediated Mechanism That Is Linked to Genes Involved in Cell Metabolism.''; PubMed Europe PMC Scholia
  6. Wenzel-Seifert K, Liu HY, Seifert R.; ''Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants.''; PubMed Europe PMC Scholia
  7. Etzerodt A, Rasmussen MR, Svendsen P, Chalaris A, Schwarz J, Galea I, Møller HJ, Moestrup SK.; ''Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.''; PubMed Europe PMC Scholia
  8. Tsang E, Giannetti AM, Shaw D, Dinh M, Tse JK, Gandhi S, Ho H, Wang S, Papp E, Bradshaw JM.; ''Molecular mechanism of the Syk activation switch.''; PubMed Europe PMC Scholia
  9. Dessauer CW, Chen-Goodspeed M, Chen J.; ''Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase.''; PubMed Europe PMC Scholia
  10. Högger P, Erpenstein U, Rohdewald P, Sorg C.; ''Biochemical characterization of a glucocorticoid-induced membrane protein (RM3/1) in human monocytes and its application as model system for ranking glucocorticoid potency.''; PubMed Europe PMC Scholia
  11. Durden DL, Liu YB.; ''Protein-tyrosine kinase p72syk in Fc gamma RI receptor signaling.''; PubMed Europe PMC Scholia
  12. Huang ZY, Barreda DR, Worth RG, Indik ZK, Kim MK, Chien P, Schreiber AD.; ''Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.''; PubMed Europe PMC Scholia
  13. Fan H, Turck CW, Derynck R.; ''Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide.''; PubMed Europe PMC Scholia
  14. Matsuda M, Paterson HF, Rodriguez R, Fensome AC, Ellis MV, Swann K, Katan M.; ''Real time fluorescence imaging of PLC gamma translocation and its interaction with the epidermal growth factor receptor.''; PubMed Europe PMC Scholia
  15. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, Tybulewicz VL, DeFranco AL.; ''A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages.''; PubMed Europe PMC Scholia
  16. Cooper JA, Hill SJ, Alexander SP, Rubin PC, Horn EH.; ''Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.''; PubMed Europe PMC Scholia
  17. Matsuda M, Park JG, Wang DC, Hunter S, Chien P, Schreiber AD.; ''Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides.''; PubMed Europe PMC Scholia
  18. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Williams DL, Zeng Z, Liu Q, Ma L, Clements MK, Coulombe N, Liu Y, Austin CP, George SR, O'Neill GP, Metters KM, Lynch KR, Evans JF.; ''Characterization of the human cysteinyl leukotriene 2 receptor.''; PubMed Europe PMC Scholia
  19. Droste A, Sorg C, Högger P.; ''Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family.''; PubMed Europe PMC Scholia
  20. Kiener PA, Rankin BM, Burkhardt AL, Schieven GL, Gilliland LK, Rowley RB, Bolen JB, Ledbetter JA.; ''Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase.''; PubMed Europe PMC Scholia
  21. Gechtman Z, Alonso JL, Raab G, Ingber DE, Klagsbrun M.; ''The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading.''; PubMed Europe PMC Scholia
  22. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, Greig GM, Kargman S, Hooks SB, Hosfield E, Williams DL, Ford-Hutchinson AW, Caskey CT, Evans JF.; ''Characterization of the human cysteinyl leukotriene CysLT1 receptor.''; PubMed Europe PMC Scholia
  23. Kelly EK, Wang L, Ivashkiv LB.; ''Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages.''; PubMed Europe PMC Scholia
  24. Linden J, Thai T, Figler H, Jin X, Robeva AS.; ''Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.''; PubMed Europe PMC Scholia
  25. Timmermann M, Buck F, Sorg C, Högger P.; ''Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type A.''; PubMed Europe PMC Scholia
  26. Carpenter G, Ji Q.; ''Phospholipase C-gamma as a signal-transducing element.''; PubMed Europe PMC Scholia
  27. Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, Davis R, Clarke HR, Petersen M, Fitzner JN, Cerretti DP, March CJ, Paxton RJ, Black RA, Bode W.; ''Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.''; PubMed Europe PMC Scholia
  28. Kozasa T, Itoh H, Tsukamoto T, Kaziro Y.; ''Isolation and characterization of the human Gs alpha gene.''; PubMed Europe PMC Scholia
  29. Högger P, Sorg C.; ''Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.''; PubMed Europe PMC Scholia
  30. Martin AL, Steurer MA, Aronstam RS.; ''Constitutive Activity among Orphan Class-A G Protein Coupled Receptors.''; PubMed Europe PMC Scholia
  31. Tesmer JJ, Sunahara RK, Gilman AG, Sprang SR.; ''Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.''; PubMed Europe PMC Scholia
  32. Leduc R, Molloy SS, Thorne BA, Thomas G.; ''Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage.''; PubMed Europe PMC Scholia
  33. Law CL, Chandran KA, Sidorenko SP, Clark EA.; ''Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk.''; PubMed Europe PMC Scholia
  34. Peterfreund RA, MacCollin M, Gusella J, Fink JS.; ''Characterization and expression of the human A2a adenosine receptor gene.''; PubMed Europe PMC Scholia
  35. Wong E, Maretzky T, Peleg Y, Blobel CP, Sagi I.; ''The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site.''; PubMed Europe PMC Scholia
  36. Yang R, Lin Q, Gao HB, Zhang P.; ''Stress-related hormone norepinephrine induces interleukin-6 expression in GES-1 cells.''; PubMed Europe PMC Scholia
  37. Padigel UM, Farrell JP.; ''Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.''; PubMed Europe PMC Scholia
  38. Cavadas M, Oikonomidi I, Gaspar CJ, Burbridge E, Badenes M, Félix I, Bolado A, Hu T, Bileck A, Gerner C, Domingos PM, von Kriegsheim A, Adrain C.; ''Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE.''; PubMed Europe PMC Scholia
  39. Strzelecka A, Kwiatkowska K, Sobota A.; ''Tyrosine phosphorylation and Fcgamma receptor-mediated phagocytosis.''; PubMed Europe PMC Scholia
  40. Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, Schmidt DB, Muccitelli RM, Jenkins O, Murdock PR, Herrity NC, Halsey W, Sathe G, Muir AI, Nuthulaganti P, Dytko GM, Buckley PT, Wilson S, Bergsma DJ, Hay DW.; ''Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.''; PubMed Europe PMC Scholia
  41. Schwarz J, Schmidt S, Will O, Koudelka T, Köhler K, Boss M, Rabe B, Tholey A, Scheller J, Schmidt-Arras D, Schwake M, Rose-John S, Chalaris A.; ''Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.''; PubMed Europe PMC Scholia
  42. Chu N, Thomas BN, Patel SR, Buxbaum LU.; ''IgG1 is pathogenic in Leishmania mexicana infection.''; PubMed Europe PMC Scholia
  43. Baker LP, Nielsen MD, Impey S, Metcalf MA, Poser SW, Chan G, Obrietan K, Hamblin MW, Storm DR.; ''Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor.''; PubMed Europe PMC Scholia
  44. Gullingsrud J, Kim C, Taylor SS, McCammon JA.; ''Dynamic binding of PKA regulatory subunit RI alpha.''; PubMed Europe PMC Scholia
  45. Mitsuhashi M, Mitsuhashi T, Payan DG.; ''Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells.''; PubMed Europe PMC Scholia
  46. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G.; ''Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.''; PubMed Europe PMC Scholia
  47. James MA, Lu Y, Liu Y, Vikis HG, You M.; ''RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway.''; PubMed Europe PMC Scholia
  48. Di Pasquale G, Stacey SN.; ''Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation.''; PubMed Europe PMC Scholia
  49. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, Postina R.; ''Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.''; PubMed Europe PMC Scholia
  50. Lupher ML, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B, Band H.; ''Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.''; PubMed Europe PMC Scholia
  51. Díaz-Rodríguez E, Montero JC, Esparís-Ogando A, Yuste L, Pandiella A.; ''Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.''; PubMed Europe PMC Scholia
  52. Etzerodt A, Maniecki MB, Møller K, Møller HJ, Moestrup SK.; ''Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.''; PubMed Europe PMC Scholia
  53. Suzuki T, Kono H, Hirose N, Okada M, Yamamoto T, Yamamoto K, Honda Z.; ''Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.''; PubMed Europe PMC Scholia
  54. Chen TY, Illing M, Molday LL, Hsu YT, Yau KW, Molday RS.; ''Subunit 2 (or beta) of retinal rod cGMP-gated cation channel is a component of the 240-kDa channel-associated protein and mediates Ca(2+)-calmodulin modulation.''; PubMed Europe PMC Scholia
  55. Lambert NA.; ''Dissociation of heterotrimeric g proteins in cells.''; PubMed Europe PMC Scholia
  56. Kim YJ, Sekiya F, Poulin B, Bae YS, Rhee SG.; ''Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2.''; PubMed Europe PMC Scholia
  57. Kim MJ, Kim E, Ryu SH, Suh PG.; ''The mechanism of phospholipase C-gamma1 regulation.''; PubMed Europe PMC Scholia
  58. Li W, Yu ZX, Kotin RM.; ''Profiles of PrKX expression in developmental mouse embryo and human tissues.''; PubMed Europe PMC Scholia
  59. Eskdale J, Kube D, Tesch H, Gallagher G.; ''Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.''; PubMed Europe PMC Scholia
  60. Burger R.; ''Impact of interleukin-6 in hematological malignancies.''; PubMed Europe PMC Scholia
  61. Wickham S, West MB, Cook PF, Hanigan MH.; ''Gamma-glutamyl compounds: substrate specificity of gamma-glutamyl transpeptidase enzymes.''; PubMed Europe PMC Scholia
  62. Fan H, Derynck R.; ''Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades.''; PubMed Europe PMC Scholia
  63. Luo Y, Zheng SG.; ''Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms.''; PubMed Europe PMC Scholia
  64. Raulf M, König W, Köller M, Stüning M.; ''Release and functional characterization of the leukotriene D4-metabolizing enzyme (dipeptidase) from human polymorphonuclear leucocytes.''; PubMed Europe PMC Scholia
  65. Sulahian TH, Högger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM.; ''Human monocytes express CD163, which is upregulated by IL-10 and identical to p155.''; PubMed Europe PMC Scholia
  66. Huang MM, Indik Z, Brass LF, Hoxie JA, Schreiber AD, Brugge JS.; ''Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII.''; PubMed Europe PMC Scholia
  67. Gonzalez GA, Montminy MR.; ''Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.''; PubMed Europe PMC Scholia
  68. Ghazizadeh S, Bolen JB, Fleit HB.; ''Tyrosine phosphorylation and association of Syk with Fc gamma RII in monocytic THP-1 cells.''; PubMed Europe PMC Scholia
  69. Furlong MT, Mahrenholz AM, Kim KH, Ashendel CL, Harrison ML, Geahlen RL.; ''Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk.''; PubMed Europe PMC Scholia
  70. Dusi S, Donini M, Della Bianca V, Rossi F.; ''Tyrosine phosphorylation of phospholipase C-gamma 2 is involved in the activation of phosphoinositide hydrolysis by Fc receptors in human neutrophils.''; PubMed Europe PMC Scholia
  71. Thomas BN, Buxbaum LU.; ''FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.''; PubMed Europe PMC Scholia
  72. Li X, Li HP, Amsler K, Hyink D, Wilson PD, Burrow CR.; ''PRKX, a phylogenetically and functionally distinct cAMP-dependent protein kinase, activates renal epithelial cell migration and morphogenesis.''; PubMed Europe PMC Scholia
  73. Pierce KD, Furlong TJ, Selbie LA, Shine J.; ''Molecular cloning and expression of an adenosine A2b receptor from human brain.''; PubMed Europe PMC Scholia
  74. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M.; ''Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE.''; PubMed Europe PMC Scholia
  75. Srour N, Lebel A, McMahon S, Fournier I, Fugère M, Day R, Dubois CM.; ''TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity.''; PubMed Europe PMC Scholia
  76. Morehead J, Coppens I, Andrews NW.; ''Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.''; PubMed Europe PMC Scholia
  77. Lee SH, Charmoy M, Romano A, Paun A, Chaves MM, Cope FO, Ralph DA, Sacks DL.; ''Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment.''; PubMed Europe PMC Scholia
  78. Agarwal A, Salem P, Robbins KC.; ''Involvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling.''; PubMed Europe PMC Scholia
  79. Dendorfer U, Oettgen P, Libermann TA.; ''Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.''; PubMed Europe PMC Scholia
  80. Liang Z, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX.; ''Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain.''; PubMed Europe PMC Scholia
  81. Adachi H, Kubota I, Okamura N, Iwata H, Tsujimoto M, Nakazato H, Nishihara T, Noguchi T.; ''Purification and characterization of human microsomal dipeptidase.''; PubMed Europe PMC Scholia
  82. Lee CW, Lewis RA, Corey EJ, Austen KF.; ''Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes.''; PubMed Europe PMC Scholia
  83. Sekiya F, Poulin B, Kim YJ, Rhee SG.; ''Mechanism of tyrosine phosphorylation and activation of phospholipase C-gamma 1. Tyrosine 783 phosphorylation is not sufficient for lipase activation.''; PubMed Europe PMC Scholia
  84. SUTHERLAND EW, RALL TW.; ''Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles.''; PubMed Europe PMC Scholia
  85. Feldman DS, Zamah AM, Pierce KL, Miller WE, Kelly F, Rapacciuolo A, Rockman HA, Koch WJ, Luttrell LM.; ''Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus.''; PubMed Europe PMC Scholia
  86. McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, Maney SK, Berger T, Murthy A, Duncan G, Xu HC, Lang KS, Häussinger D, Wakeham A, Itie-Youten A, Khokha R, Ohashi PS, Blobel CP, Mak TW.; ''iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS.''; PubMed Europe PMC Scholia
  87. Zhang J, Berenstein E, Siraganian RP.; ''Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc epsilon RI signaling in mast cells.''; PubMed Europe PMC Scholia
  88. El-Hillal O, Kurosaki T, Yamamura H, Kinet JP, Scharenberg AM.; ''syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction.''; PubMed Europe PMC Scholia
  89. Anderson ME, Allison RD, Meister A.; ''Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids.''; PubMed Europe PMC Scholia
  90. Nagakura A, Takagi N, Takeo S.; ''Impairment of cerebral cAMP-mediated signal transduction system and of spatial memory function after microsphere embolism in rats.''; PubMed Europe PMC Scholia
  91. Xu P, Derynck R.; ''Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.''; PubMed Europe PMC Scholia
  92. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD.; ''Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs.''; PubMed Europe PMC Scholia
  93. Wenzel I, Roth J, Sorg C.; ''Identification of a novel surface molecule, RM3/1, that contributes to the adhesion of glucocorticoid-induced human monocytes to endothelial cells.''; PubMed Europe PMC Scholia
  94. Gu C, Cooper DM.; ''Calmodulin-binding sites on adenylyl cyclase type VIII.''; PubMed Europe PMC Scholia
  95. Bandeira-Melo C, Woods LJ, Phoofolo M, Weller PF.; ''Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion.''; PubMed Europe PMC Scholia

History

CompareRevisionActionTimeUserComment
114834view16:33, 25 January 2021ReactomeTeamReactome version 75
113280view11:35, 2 November 2020ReactomeTeamReactome version 74
112811view18:18, 9 October 2020DeSlOntology Term : 'Leishmaniasis pathway' added !
112759view16:16, 9 October 2020ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
5HT MetaboliteCHEBI:28790 (ChEBI)
ADAM17(1-214)ProteinP78536 (Uniprot-TrEMBL)
ADAM17(215-827) ProteinP78536 (Uniprot-TrEMBL)
ADAM17(215-827):Zn2+ComplexR-HSA-9662765 (Reactome)
ADAM17(215-827):Zn2+ComplexR-HSA-9662793 (Reactome)
ADAM17(215-827)ProteinP78536 (Uniprot-TrEMBL)
ADAM17ProteinP78536 (Uniprot-TrEMBL)
ADCY1 ProteinQ08828 (Uniprot-TrEMBL)
ADCY2 ProteinQ08462 (Uniprot-TrEMBL)
ADCY3 ProteinO60266 (Uniprot-TrEMBL)
ADCY4 ProteinQ8NFM4 (Uniprot-TrEMBL)
ADCY5 ProteinO95622 (Uniprot-TrEMBL)
ADCY6 ProteinO43306 (Uniprot-TrEMBL)
ADCY7 ProteinP51828 (Uniprot-TrEMBL)
ADCY8 ProteinP40145 (Uniprot-TrEMBL)
ADCY9 ProteinO60503 (Uniprot-TrEMBL)
ADCYAP1(132-158) ProteinP18509 (Uniprot-TrEMBL)
ADCYAP1(132-169) ProteinP18509 (Uniprot-TrEMBL)
ADCYAP1(82-129) ProteinP18509 (Uniprot-TrEMBL)
ADCYAP1R1 ProteinP41586 (Uniprot-TrEMBL)
ADM(95-146) ProteinP35318 (Uniprot-TrEMBL)
ADM2(19-153) ProteinQ7Z4H4 (Uniprot-TrEMBL)
ADORA2A ProteinP29274 (Uniprot-TrEMBL)
ADORA2B ProteinP29275 (Uniprot-TrEMBL)
ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTPComplexR-HSA-9660820 (Reactome)
ADORA2B:Ade-RibComplexR-HSA-9660818 (Reactome)
ADORA2BProteinP29275 (Uniprot-TrEMBL)
ADPMetaboliteCHEBI:456216 (ChEBI)
ADR MetaboliteCHEBI:28918 (ChEBI)
ADRB1 ProteinP08588 (Uniprot-TrEMBL)
ADRB2 ProteinP07550 (Uniprot-TrEMBL)
ADRB3 ProteinP13945 (Uniprot-TrEMBL)
AHCYL1 ProteinO43865 (Uniprot-TrEMBL)
AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramerComplexR-HSA-5226920 (Reactome)
ATP MetaboliteCHEBI:30616 (ChEBI)
ATPMetaboliteCHEBI:30616 (ChEBI)
AVP(20-28) ProteinP01185 (Uniprot-TrEMBL)
AVPR2 ProteinP30518 (Uniprot-TrEMBL)
Ade-Rib MetaboliteCHEBI:16335 (ChEBI)
Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDPComplexR-HSA-9660817 (Reactome)
Ade-RibMetaboliteCHEBI:16335 (ChEBI)
Adenylate cyclase (Mg2+ cofactor)ComplexR-HSA-170665 (Reactome)
Antigen R-ALL-173548 (Reactome)
ArgN-GCG(98-127) ProteinP01275 (Uniprot-TrEMBL) The amide group at the C-terminus is not necessary for biological activity.
CALCA(83-119) ProteinP01258 (Uniprot-TrEMBL)
CALCA(83-119) ProteinP06881 (Uniprot-TrEMBL)
CALCB(82-118) ProteinP10092 (Uniprot-TrEMBL)
CALCR ProteinP30988 (Uniprot-TrEMBL)
CALCRL ProteinQ16602 (Uniprot-TrEMBL)
CALM1 ProteinP0DP23 (Uniprot-TrEMBL)
CALM1:4xCa2+ComplexR-HSA-74294 (Reactome)
CALM1ProteinP0DP23 (Uniprot-TrEMBL)
CCA MetaboliteCHEBI:16359 (ChEBI)
CD163 geneGeneProductENSG00000177575 (Ensembl)
CD163(1051-1156)ProteinQ86VB7 (Uniprot-TrEMBL)
CD163ProteinQ86VB7 (Uniprot-TrEMBL)
CD247-1 ProteinP20963-1 (Uniprot-TrEMBL)
CD3G ProteinP09693 (Uniprot-TrEMBL)
CDCA MetaboliteCHEBI:16755 (ChEBI)
CGA ProteinP01215 (Uniprot-TrEMBL)
CREB1ProteinP16220 (Uniprot-TrEMBL)
CRH ProteinP06850 (Uniprot-TrEMBL)
CRHR1 ProteinP34998 (Uniprot-TrEMBL)
CRHR2 ProteinQ13324 (Uniprot-TrEMBL)
CYSLTR1 ProteinQ9Y271 (Uniprot-TrEMBL)
CYSLTR1,CYSLTR2ComplexR-HSA-416385 (Reactome)
CYSLTR2 ProteinQ9NS75 (Uniprot-TrEMBL)
Ca2+ MetaboliteCHEBI:29108 (ChEBI)
Ca2+MetaboliteCHEBI:29108 (ChEBI)
Constitutively active orphan GPCRs R-HSA-6805225 (Reactome)
DA MetaboliteCHEBI:18243 (ChEBI)
DAGsMetaboliteCHEBI:18035 (ChEBI)
DCA MetaboliteCHEBI:28834 (ChEBI)
DPEP1 ProteinP16444 (Uniprot-TrEMBL)
DPEP1,2,3 dimersComplexR-HSA-2162149 (Reactome)
DPEP2 ProteinQ9H4A9 (Uniprot-TrEMBL)
DPEP3 ProteinQ9H4B8 (Uniprot-TrEMBL)
DRD1 ProteinP21728 (Uniprot-TrEMBL)
DRD5 ProteinP21918 (Uniprot-TrEMBL)
FCGR1A ProteinP12314 (Uniprot-TrEMBL)
FCGR3A ProteinP08637 (Uniprot-TrEMBL)
FCGRIIIA:CD3G/CD3Z dimersComplexR-HSA-2029097 (Reactome)
FGR ProteinP09769 (Uniprot-TrEMBL)
FSHB ProteinP01225 (Uniprot-TrEMBL)
FSHR ProteinP23945 (Uniprot-TrEMBL)
FURINProteinP09958 (Uniprot-TrEMBL)
FYN ProteinP06241 (Uniprot-TrEMBL)
G alpha

(s):GTP:Adenylate

cyclase		ComplexR-HSA-163622 (Reactome)
G alpha (s):GTPComplexR-HSA-164358 (Reactome)
G-betagammaR-HSA-111865 (Reactome)
G-protein alpha

(i):GTP:Adenylate

cyclase		ComplexR-HSA-396910 (Reactome)
G-protein alpha

(z):GTP:Adenylate

cyclase		ComplexR-HSA-392049 (Reactome)
G-protein beta-gamma complexComplexR-HSA-167434 (Reactome)
GCG(146-178) ProteinP01275 (Uniprot-TrEMBL)
GCG(53-81) ProteinP01275 (Uniprot-TrEMBL)
GDP MetaboliteCHEBI:17552 (ChEBI)
GDPMetaboliteCHEBI:17552 (ChEBI)
GGT1 dimerComplexR-HSA-1247898 (Reactome)
GGT1(1-380) ProteinP19440 (Uniprot-TrEMBL)
GGT1(381-569) ProteinP19440 (Uniprot-TrEMBL)
GGT1, 5 dimersComplexR-HSA-2162130 (Reactome)
GGT5(1-387) ProteinP36269 (Uniprot-TrEMBL)
GGT5(388-586) ProteinP36269 (Uniprot-TrEMBL)
GHRH ProteinP01286 (Uniprot-TrEMBL)
GHRHR ProteinQ02643 (Uniprot-TrEMBL)
GIP(52-93) ProteinP09681 (Uniprot-TrEMBL)
GIPR ProteinP48546 (Uniprot-TrEMBL)
GLP-1 (7-37) ProteinP01275 (Uniprot-TrEMBL)
GLP1R ProteinP43220 (Uniprot-TrEMBL)
GLP2R ProteinO95838 (Uniprot-TrEMBL)
GNAI1 ProteinP63096 (Uniprot-TrEMBL)
GNAI2 ProteinP04899 (Uniprot-TrEMBL)
GNAI3 ProteinP08754 (Uniprot-TrEMBL)
GNAS1 ProteinQ5JWF2 (Uniprot-TrEMBL)
GNAS2 ProteinP63092 (Uniprot-TrEMBL)
GNAT3 ProteinA8MTJ3 (Uniprot-TrEMBL)
GNAZ ProteinP19086 (Uniprot-TrEMBL)
GNB1 ProteinP62873 (Uniprot-TrEMBL)
GNB2 ProteinP62879 (Uniprot-TrEMBL)
GNB3 ProteinP16520 (Uniprot-TrEMBL)
GNB4 ProteinQ9HAV0 (Uniprot-TrEMBL)
GNB5 ProteinO14775 (Uniprot-TrEMBL)
GNG10 ProteinP50151 (Uniprot-TrEMBL)
GNG11 ProteinP61952 (Uniprot-TrEMBL)
GNG12 ProteinQ9UBI6 (Uniprot-TrEMBL)
GNG13 ProteinQ9P2W3 (Uniprot-TrEMBL)
GNG2 ProteinP59768 (Uniprot-TrEMBL)
GNG3 ProteinP63215 (Uniprot-TrEMBL)
GNG4 ProteinP50150 (Uniprot-TrEMBL)
GNG5 ProteinP63218 (Uniprot-TrEMBL)
GNG7 ProteinO60262 (Uniprot-TrEMBL)
GNG8 ProteinQ9UK08 (Uniprot-TrEMBL)
GNGT1 ProteinP63211 (Uniprot-TrEMBL)
GNGT2 ProteinO14610 (Uniprot-TrEMBL)
GPBAR1 ProteinQ8TDU6 (Uniprot-TrEMBL)
GPHA2 ProteinQ96T91 (Uniprot-TrEMBL)
GPHB5 ProteinQ86YW7 (Uniprot-TrEMBL)
GPR39 ProteinO43194 (Uniprot-TrEMBL)
GTP MetaboliteCHEBI:15996 (ChEBI)
GTPMetaboliteCHEBI:15996 (ChEBI)
Glucocorticoid, IL6, IL10ComplexR-HSA-9662737 (Reactome)
GlyMetaboliteCHEBI:57305 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
HCK ProteinP08631 (Uniprot-TrEMBL)
HRH2 ProteinP25021 (Uniprot-TrEMBL)
HTR4 ProteinQ13639 (Uniprot-TrEMBL)
HTR6 ProteinP50406 (Uniprot-TrEMBL)
HTR7 ProteinP34969 (Uniprot-TrEMBL)
Heterotrimeric

G-protein Gs

(inactive)		ComplexR-HSA-391179 (Reactome)
Hist MetaboliteCHEBI:18295 (ChEBI)
I(1,4,5)P3 MetaboliteCHEBI:16595 (ChEBI)
I(1,4,5)P3MetaboliteCHEBI:16595 (ChEBI)
IAPP(34-70) ProteinP10997 (Uniprot-TrEMBL)
IGHG1 ProteinP01857 (Uniprot-TrEMBL)
IGHG2 ProteinP01859 (Uniprot-TrEMBL)
IGHG3 ProteinP01860 (Uniprot-TrEMBL)
IGHG4 ProteinP01861 (Uniprot-TrEMBL)
IGHV(1-?) ProteinA2KUC3 (Uniprot-TrEMBL)
IGHV1-2 ProteinP23083 (Uniprot-TrEMBL)
IGHV7-81(1-?) ProteinQ6PIL0 (Uniprot-TrEMBL)
IGKC ProteinP01834 (Uniprot-TrEMBL)
IGKV1-12 ProteinA0A0C4DH73 (Uniprot-TrEMBL)
IGKV1-5(23-?) ProteinP01602 (Uniprot-TrEMBL)
IGKV2-28 ProteinA0A075B6P5 (Uniprot-TrEMBL)
IGKV2D-30 ProteinA0A075B6S6 (Uniprot-TrEMBL)
IGKV3D-20 ProteinA0A0C4DH25 (Uniprot-TrEMBL)
IGKV4-1(21-?) ProteinP06312 (Uniprot-TrEMBL)
IGKVA18(21-?) ProteinA2NJV5 (Uniprot-TrEMBL)
IGLC1 ProteinP0CG04 (Uniprot-TrEMBL)
IGLC2 ProteinP0DOY2 (Uniprot-TrEMBL)
IGLC3 ProteinP0DOY3 (Uniprot-TrEMBL)
IGLC6 ProteinP0CF74 (Uniprot-TrEMBL)
IGLC7 ProteinA0M8Q6 (Uniprot-TrEMBL)
IGLV(23-?) ProteinA2NXD2 (Uniprot-TrEMBL)
IGLV1-36(1-?) ProteinQ5NV67 (Uniprot-TrEMBL)
IGLV1-40(1-?) ProteinQ5NV69 (Uniprot-TrEMBL)
IGLV1-44(1-?) ProteinQ5NV81 (Uniprot-TrEMBL)
IGLV10-54(1-?) ProteinQ5NV86 (Uniprot-TrEMBL)
IGLV11-55(1-?) ProteinQ5NV87 (Uniprot-TrEMBL)
IGLV2-11(1-?) ProteinQ5NV84 (Uniprot-TrEMBL)
IGLV2-18(1-?) ProteinQ5NV65 (Uniprot-TrEMBL)
IGLV2-23(1-?) ProteinQ5NV89 (Uniprot-TrEMBL)
IGLV2-33(1-?) ProteinQ5NV66 (Uniprot-TrEMBL)
IGLV3-12(1-?) ProteinQ5NV85 (Uniprot-TrEMBL)
IGLV3-16(1-?) ProteinQ5NV64 (Uniprot-TrEMBL)
IGLV3-22(1-?) ProteinQ5NV75 (Uniprot-TrEMBL)
IGLV3-25(1-?) ProteinQ5NV90 (Uniprot-TrEMBL)
IGLV3-27(1-?) ProteinQ5NV91 (Uniprot-TrEMBL)
IGLV4-3(1-?) ProteinQ5NV61 (Uniprot-TrEMBL)
IGLV4-60(1-?) ProteinQ5NV79 (Uniprot-TrEMBL)
IGLV4-69(1-?) ProteinQ5NV92 (Uniprot-TrEMBL)
IGLV5-37(1-?) ProteinQ5NV68 (Uniprot-TrEMBL)
IGLV5-45(1-?) ProteinQ5NV82 (Uniprot-TrEMBL)
IGLV7-43(1-?) ProteinQ5NV80 (Uniprot-TrEMBL)
IGLV7-46(1-?) ProteinQ5NV83 (Uniprot-TrEMBL)
IGLV8-61(1-?) ProteinQ5NV62 (Uniprot-TrEMBL)
IL10 ProteinP22301 (Uniprot-TrEMBL)
IL10 gene ProteinENSG00000136634 (Ensembl)
IL10 geneGeneProductENSG00000136634 (Ensembl)
IL10ProteinP22301 (Uniprot-TrEMBL)
IL6 ProteinP05231 (Uniprot-TrEMBL)
IL6 gene ProteinENSG00000136244 (Ensembl)
IL6 geneGeneProductENSG00000136244 (Ensembl)
IL6ProteinP05231 (Uniprot-TrEMBL)
INSL3(106-131) ProteinP51460 (Uniprot-TrEMBL)
INSL3(21-55) ProteinP51460 (Uniprot-TrEMBL)
IP3 receptor homotetramerComplexR-HSA-169686 (Reactome)
ITPR1 ProteinQ14643 (Uniprot-TrEMBL)
ITPR2 ProteinQ14571 (Uniprot-TrEMBL)
ITPR3 ProteinQ14573 (Uniprot-TrEMBL)
ITPR:I(1,4,5)P3 tetramerComplexR-HSA-169696 (Reactome)
Ig heavy chain V-I region EU ProteinP01742 (Uniprot-TrEMBL)
Ig heavy chain V-I region HG3 ProteinP01743 (Uniprot-TrEMBL)
Ig heavy chain V-II region ARH-77 ProteinP06331 (Uniprot-TrEMBL)
Ig heavy chain V-II region MCE ProteinP01817 (Uniprot-TrEMBL)
Ig heavy chain V-II region NEWM ProteinP01825 (Uniprot-TrEMBL)
Ig heavy chain V-II region OU ProteinP01814 (Uniprot-TrEMBL)
Ig heavy chain V-II region WAH ProteinP01824 (Uniprot-TrEMBL)
Ig heavy chain V-III region BRO ProteinP01766 (Uniprot-TrEMBL)
Ig heavy chain V-III region BUT ProteinP01767 (Uniprot-TrEMBL)
Ig heavy chain V-III region CAM ProteinP01768 (Uniprot-TrEMBL)
Ig heavy chain V-III region DOB ProteinP01782 (Uniprot-TrEMBL)
Ig heavy chain V-III region JON ProteinP01780 (Uniprot-TrEMBL)
Ig heavy chain V-III region KOL ProteinP01772 (Uniprot-TrEMBL)
Ig heavy chain V-III region TRO ProteinP01762 (Uniprot-TrEMBL)
Ig heavy chain V-III region WEA ProteinP01763 (Uniprot-TrEMBL)
Ig kappa chain V region EV15 ProteinP06315 (Uniprot-TrEMBL)
Ig kappa chain V-I region AG ProteinP01593 (Uniprot-TrEMBL)
Ig kappa chain V-I region AU ProteinP01594 (Uniprot-TrEMBL)
Ig kappa chain V-I region BAN ProteinP04430 (Uniprot-TrEMBL)
Ig kappa chain V-I region DEE ProteinP01597 (Uniprot-TrEMBL)
Ig kappa chain V-I region Daudi ProteinP04432 (Uniprot-TrEMBL)
Ig kappa chain V-I region Gal ProteinP01599 (Uniprot-TrEMBL)
Ig kappa chain V-I region HK101 ProteinP01601 (Uniprot-TrEMBL)
Ig kappa chain V-I region Wes ProteinP01611 (Uniprot-TrEMBL)
Ig kappa chain V-II region Cum ProteinP01614 (Uniprot-TrEMBL)
Ig kappa chain V-II region FR ProteinP01615 (Uniprot-TrEMBL)
Ig kappa chain V-II region RPMI 6410 ProteinP06310 (Uniprot-TrEMBL)
Ig kappa chain V-III region B6 ProteinP01619 (Uniprot-TrEMBL)
Ig kappa chain V-III region POM ProteinP01624 (Uniprot-TrEMBL)
Ig kappa chain V-III region VG ProteinP04433 (Uniprot-TrEMBL)
Ig lambda chain V region 4A ProteinP04211 (Uniprot-TrEMBL)
Ig lambda chain V-I region HA ProteinP01700 (Uniprot-TrEMBL)
Ig lambda chain V-I region NEW ProteinP01701 (Uniprot-TrEMBL)
Ig lambda chain V-I region NEWM ProteinP01703 (Uniprot-TrEMBL)
Ig lambda chain V-I region VOR ProteinP01699 (Uniprot-TrEMBL)
Ig lambda chain V-II region BOH ProteinP01706 (Uniprot-TrEMBL)
Ig lambda chain V-II region MGC ProteinP01709 (Uniprot-TrEMBL)
Ig lambda chain V-II region NEI ProteinP01705 (Uniprot-TrEMBL)
Ig lambda chain V-II region TOG ProteinP01704 (Uniprot-TrEMBL)
Ig lambda chain V-III region LOI ProteinP80748 (Uniprot-TrEMBL)
Ig lambda chain V-III region SH ProteinP01714 (Uniprot-TrEMBL)
Ig lambda chain V-IV region Bau ProteinP01715 (Uniprot-TrEMBL)
Ig lambda chain V-IV region Hil ProteinP01717 (Uniprot-TrEMBL)
Ig lambda chain V-IV region Kern ProteinP01718 (Uniprot-TrEMBL)
Ig lambda chain V-VI region AR ProteinP01721 (Uniprot-TrEMBL)
IgG:LPG1G2ComplexR-HSA-9675736 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCGComplexR-HSA-9664277 (Reactome)
IgG:Leishmania surface:p-FCGR3As:p-6Y-SYK:PLCGComplexR-HSA-9664266 (Reactome)
IgG:Lma

antigens:FCGR3A:CD3

dimers		ComplexR-HSA-9664263 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:SYKComplexR-HSA-9664272 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKComplexR-HSA-9664265 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersComplexR-HSA-9664282 (Reactome)
IgG:Lma amastigote surfaceComplexR-HSA-9664283 (Reactome)
IgG:Lma antigensComplexR-HSA-9666422 (Reactome)
IgGComplexR-HSA-182629 (Reactome) In view of the highly variable nature of antibody proteins, this biological object is an approximate and fragmented representation of an IgM/IgD antibody, given the limitations of Ig chain enumeration in UniProt. A single mRNA transcript is alternatively spliced to give either IgM or IgD. Thus unactivated B cells contain both classes of antibody.
IgH heavy chain V-III region VH26 precursor ProteinP01764 (Uniprot-TrEMBL)
L-GluMetaboliteCHEBI:29985 (ChEBI)
LCHA MetaboliteCHEBI:16325 (ChEBI)
LHB ProteinP01229 (Uniprot-TrEMBL)
LHCGR ProteinP22888 (Uniprot-TrEMBL)
LPG1G2 ProteinQ4QD44 (Uniprot-TrEMBL)
LPG1G2ProteinQ4QD44 (Uniprot-TrEMBL)
LTC4 MetaboliteCHEBI:16978 (ChEBI)
LTC4:CyslTR1,2ComplexR-HSA-9664302 (Reactome)
LTC4MetaboliteCHEBI:16978 (ChEBI)
LTD4MetaboliteCHEBI:28666 (ChEBI)
LTE4MetaboliteCHEBI:15650 (ChEBI)
LYN ProteinP07948 (Uniprot-TrEMBL)
Ligand:GPCR

complexes that activate Gs:Heterotrimeric G-protein Gs

(inactive)		ComplexR-HSA-744885 (Reactome)
Lma amastigote surfaceR-LMA-9664274 (Reactome) This entity is intended to represent any molecule that might be at the outer cell surface of a Leishmania amastigote parasite.
Lma amastigote surface R-LMA-9664274 (Reactome) This entity is intended to represent any molecule that might be at the outer cell surface of a Leishmania amastigote parasite.
MC1R ProteinQ01726 (Uniprot-TrEMBL)
MC2R ProteinQ01718 (Uniprot-TrEMBL)
MC3R(1-360) ProteinP41968 (Uniprot-TrEMBL)
MC4R ProteinP32245 (Uniprot-TrEMBL)
MC5R ProteinP33032 (Uniprot-TrEMBL)
MYH9 ProteinP35579 (Uniprot-TrEMBL)
MYH9ProteinP35579 (Uniprot-TrEMBL)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
NAD+ MetaboliteCHEBI:57540 (ChEBI)
NAd MetaboliteCHEBI:18357 (ChEBI)
NPS ProteinP0C0P6 (Uniprot-TrEMBL)
NPSR1 ProteinQ6W5P4 (Uniprot-TrEMBL)
P2RY11 ProteinQ96G91 (Uniprot-TrEMBL)
PEA MetaboliteCHEBI:18397 (ChEBI)
PGD2 MetaboliteCHEBI:15555 (ChEBI)
PGE2 MetaboliteCHEBI:15551 (ChEBI)
PGI2 MetaboliteCHEBI:15552 (ChEBI)
PI(3,4,5)P3 MetaboliteCHEBI:16618 (ChEBI)
PI(3,4,5)P3MetaboliteCHEBI:16618 (ChEBI)
PI(4,5)P2MetaboliteCHEBI:18348 (ChEBI)
PKA catalytic subunitComplexR-HSA-111920 (Reactome)
PKA tetramer:4xcAMPComplexR-HSA-8951729 (Reactome)
PKA tetramerComplexR-HSA-111922 (Reactome)
PLC gamma1,2ComplexR-HSA-1169089 (Reactome)
PLCG1 ProteinP19174 (Uniprot-TrEMBL)
PLCG2 ProteinP16885 (Uniprot-TrEMBL)
PLK2 ProteinQ9NYY3 (Uniprot-TrEMBL)
PLK2, MAPK14ComplexR-HSA-9662745 (Reactome)
POMC(138-150) ProteinP01189 (Uniprot-TrEMBL)
POMC(138-176) ProteinP01189 (Uniprot-TrEMBL)
POMC(217-234) ProteinP01189 (Uniprot-TrEMBL)
POMC(77-87) ProteinP01189 (Uniprot-TrEMBL)
PPiMetaboliteCHEBI:29888 (ChEBI)
PRKACA ProteinP17612 (Uniprot-TrEMBL)
PRKACA,(PRKACB,PRKACG,PRKX)ComplexR-HSA-9615387 (Reactome)
PRKACB ProteinP22694 (Uniprot-TrEMBL)
PRKACG ProteinP22612 (Uniprot-TrEMBL)
PRKAR1A ProteinP10644 (Uniprot-TrEMBL)
PRKAR1B ProteinP31321 (Uniprot-TrEMBL)
PRKAR2A ProteinP13861 (Uniprot-TrEMBL)
PRKAR2B ProteinP31323 (Uniprot-TrEMBL)
PRKX ProteinP51817 (Uniprot-TrEMBL)
PTGDR ProteinQ13258 (Uniprot-TrEMBL)
PTGER2 ProteinP43116 (Uniprot-TrEMBL)
PTGER4 ProteinP35408 (Uniprot-TrEMBL)
PTGIR ProteinP43119 (Uniprot-TrEMBL)
PTH ProteinP01270 (Uniprot-TrEMBL)
PTH1R ProteinQ03431 (Uniprot-TrEMBL)
PTH2(62-100) ProteinQ96A98 (Uniprot-TrEMBL)
PTH2R ProteinP49190 (Uniprot-TrEMBL)
PTHLH ProteinP12272 (Uniprot-TrEMBL)
Protein Kinase A, catalytic subunitsComplexR-HSA-111917 (Reactome)
RAMP1 ProteinO60894 (Uniprot-TrEMBL)
RAMP2 ProteinO60895 (Uniprot-TrEMBL)
RAMP3 ProteinO60896 (Uniprot-TrEMBL)
RLN2(162-185) ProteinP04090 (Uniprot-TrEMBL)
RLN2(25-53) ProteinP04090 (Uniprot-TrEMBL)
RLN3(119-142) ProteinQ8WXF3 (Uniprot-TrEMBL)
RLN3(26-52) ProteinQ8WXF3 (Uniprot-TrEMBL)
RXFP1 ProteinQ9HBX9 (Uniprot-TrEMBL)
RXFP2 ProteinQ8WXD0 (Uniprot-TrEMBL)
SCT ProteinP09683 (Uniprot-TrEMBL)
SCTR ProteinP47872 (Uniprot-TrEMBL)
SRC-1 ProteinP12931-1 (Uniprot-TrEMBL)
SYK ProteinP43405 (Uniprot-TrEMBL)
SYKProteinP43405 (Uniprot-TrEMBL)
Src family kinases (SFKs)ComplexR-HSA-1861597 (Reactome)
TAAR1 ProteinQ96RJ0 (Uniprot-TrEMBL)
TAAR2 ProteinQ9P1P5 (Uniprot-TrEMBL)
TAAR3 ProteinQ9P1P4 (Uniprot-TrEMBL)
TAAR5 ProteinO14804 (Uniprot-TrEMBL)
TAAR6 ProteinQ96RI8 (Uniprot-TrEMBL)
TAAR8 ProteinQ969N4 (Uniprot-TrEMBL)
TAAR9 ProteinQ96RI9 (Uniprot-TrEMBL)
TSHB ProteinP01222 (Uniprot-TrEMBL)
TSHR ProteinP16473 (Uniprot-TrEMBL)
VIP(125-152) ProteinP01282 (Uniprot-TrEMBL)
VIPR1 ProteinP32241 (Uniprot-TrEMBL)
VIPR2 ProteinP41587 (Uniprot-TrEMBL)
YES1 ProteinP07947 (Uniprot-TrEMBL)
Zn2+ MetaboliteCHEBI:29105 (ChEBI)
Zn2+MetaboliteCHEBI:29105 (ChEBI)
cAMP MetaboliteCHEBI:17489 (ChEBI)
cAMP:PKA regulatory subunitComplexR-HSA-111923 (Reactome)
cAMPMetaboliteCHEBI:17489 (ChEBI)
clustered IgG-Ag:p-FCGRs:p-6Y-SYK:PLCGComplexR-HSA-2029137 (Reactome)
glucocorticoid MetaboliteCHEBI:24261 (ChEBI)
iRHOM2ProteinQ6PJF5 (Uniprot-TrEMBL)
p-4Y-PLCG1 ProteinP19174 (Uniprot-TrEMBL)
p-6Y-CD247 ProteinP20963-1 (Uniprot-TrEMBL)
p-6Y-SYK ProteinP43405 (Uniprot-TrEMBL)
p-PLCGComplexR-HSA-2029095 (Reactome)
p-S,T-ADAM17(215-827):Zn2+ComplexR-HSA-9662806 (Reactome)
p-S133-CREB1 ProteinP16220 (Uniprot-TrEMBL)
p-S133-CREB1:IL10 geneComplexR-HSA-9664324 (Reactome)
p-S133-CREB1:IL6 geneComplexR-HSA-9662709 (Reactome)
p-S133-CREB1ProteinP16220 (Uniprot-TrEMBL)
p-T180,Y182-MAPK14 ProteinQ16539 (Uniprot-TrEMBL)
p-Y160,Y171-CD3G ProteinP09693 (Uniprot-TrEMBL)
p-Y288,Y304-FCGR2A ProteinP12318 (Uniprot-TrEMBL)
p-Y753,Y759,Y1217-PLCG2 ProteinP16885 (Uniprot-TrEMBL)
sCD163 ProteinQ86VB7 (Uniprot-TrEMBL)
sCD163:MYH9ComplexR-HSA-9663429 (Reactome)
sCD163ProteinQ86VB7 (Uniprot-TrEMBL)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
ADAM17(1-214)ArrowR-HSA-9662786 (Reactome)
ADAM17(215-827):Zn2+ArrowR-HSA-9662773 (Reactome)
ADAM17(215-827):Zn2+ArrowR-HSA-9662818 (Reactome)
ADAM17(215-827):Zn2+R-HSA-9662818 (Reactome)
ADAM17(215-827):Zn2+R-HSA-9662823 (Reactome)
ADAM17(215-827)ArrowR-HSA-9662786 (Reactome)
ADAM17(215-827)R-HSA-9662773 (Reactome)
ADAM17ArrowR-HSA-9662747 (Reactome)
ADAM17R-HSA-9662747 (Reactome)
ADAM17R-HSA-9662786 (Reactome)
ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTPArrowR-HSA-9660824 (Reactome)
ADORA2B:Ade-Rib:Heterotrimeric G-protein Gs:GTPR-HSA-9660819 (Reactome)
ADORA2B:Ade-RibArrowR-HSA-9660829 (Reactome)
ADORA2B:Ade-RibR-HSA-9660828 (Reactome)
ADORA2BArrowR-HSA-9660819 (Reactome)
ADORA2BR-HSA-9660829 (Reactome)
ADPArrowR-HSA-111919 (Reactome)
ADPArrowR-HSA-9662823 (Reactome)
ADPArrowR-HSA-9664261 (Reactome)
ADPArrowR-HSA-9664275 (Reactome)
ADPArrowR-HSA-9664278 (Reactome)
AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramerTBarR-HSA-169683 (Reactome)
ATPR-HSA-111919 (Reactome)
ATPR-HSA-111930 (Reactome)
ATPR-HSA-392129 (Reactome)
ATPR-HSA-9662823 (Reactome)
ATPR-HSA-9664261 (Reactome)
ATPR-HSA-9664275 (Reactome)
ATPR-HSA-9664278 (Reactome)
Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDPArrowR-HSA-9660828 (Reactome)
Ade-Rib:ADORA2B:Heterotrimeric G-protein Gs:GDPR-HSA-9660824 (Reactome)
Ade-RibArrowR-HSA-9660819 (Reactome)
Ade-RibR-HSA-9660829 (Reactome)
Adenylate cyclase (Mg2+ cofactor)R-HSA-163617 (Reactome)
Adenylate cyclase (Mg2+ cofactor)mim-catalysisR-HSA-111930 (Reactome)
CALM1:4xCa2+ArrowR-HSA-111930 (Reactome)
CALM1:4xCa2+ArrowR-HSA-74448 (Reactome)
CALM1R-HSA-74448 (Reactome)
CD163 geneR-HSA-9662781 (Reactome)
CD163(1051-1156)ArrowR-HSA-9662837 (Reactome)
CD163ArrowR-HSA-9662781 (Reactome)
CD163R-HSA-9662837 (Reactome)
CREB1R-HSA-111919 (Reactome)
CYSLTR1,CYSLTR2R-HSA-9664306 (Reactome)
Ca2+ArrowR-HSA-169683 (Reactome)
Ca2+R-HSA-169683 (Reactome)
Ca2+R-HSA-74448 (Reactome)
DAGsArrowR-HSA-202407 (Reactome)
DPEP1,2,3 dimersmim-catalysisR-HSA-266012 (Reactome)
FCGRIIIA:CD3G/CD3Z dimersR-HSA-9664268 (Reactome)
FURINmim-catalysisR-HSA-9662786 (Reactome)
G alpha

(s):GTP:Adenylate

cyclase		ArrowR-HSA-163617 (Reactome)
G alpha

(s):GTP:Adenylate

cyclase		mim-catalysisR-HSA-392129 (Reactome)
G alpha (s):GTPArrowR-HSA-9660819 (Reactome)
G alpha (s):GTPR-HSA-163617 (Reactome)
G-betagammaTBarR-HSA-111930 (Reactome)
G-protein alpha

(i):GTP:Adenylate

cyclase		TBarR-HSA-392129 (Reactome)
G-protein alpha

(z):GTP:Adenylate

cyclase		TBarR-HSA-392129 (Reactome)
G-protein beta-gamma complexArrowR-HSA-9660819 (Reactome)
GDPArrowR-HSA-9660824 (Reactome)
GGT1 dimerTBarR-HSA-9664306 (Reactome)
GGT1, 5 dimersmim-catalysisR-HSA-266046 (Reactome)
GTPR-HSA-9660824 (Reactome)
Glucocorticoid, IL6, IL10ArrowR-HSA-9662781 (Reactome)
GlyArrowR-HSA-266012 (Reactome)
H2OR-HSA-202407 (Reactome)
H2OR-HSA-266012 (Reactome)
H2OR-HSA-266046 (Reactome)
Heterotrimeric

G-protein Gs

(inactive)		R-HSA-9660828 (Reactome)
I(1,4,5)P3ArrowR-HSA-169683 (Reactome)
I(1,4,5)P3ArrowR-HSA-202407 (Reactome)
I(1,4,5)P3R-HSA-169680 (Reactome)
IL10 geneR-HSA-9664332 (Reactome)
IL10 geneR-HSA-9664346 (Reactome)
IL10ArrowR-HSA-9664346 (Reactome)
IL6 geneR-HSA-9662708 (Reactome)
IL6 geneR-HSA-9662710 (Reactome)
IL6ArrowR-HSA-9662710 (Reactome)
IP3 receptor homotetramerR-HSA-169680 (Reactome)
ITPR:I(1,4,5)P3 tetramerArrowR-HSA-169680 (Reactome)
ITPR:I(1,4,5)P3 tetramermim-catalysisR-HSA-169683 (Reactome)
IgG:LPG1G2ArrowR-HSA-9664397 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCGArrowR-HSA-9664278 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:p-3Y-PLCGR-HSA-9664271 (Reactome)
IgG:Leishmania surface:p-FCGR3As:p-6Y-SYK:PLCGArrowR-HSA-9664270 (Reactome)
IgG:Leishmania surface:p-FCGR3As:p-6Y-SYK:PLCGR-HSA-9664278 (Reactome)
IgG:Lma

antigens:FCGR3A:CD3

dimers		ArrowR-HSA-9664268 (Reactome)
IgG:Lma

antigens:FCGR3A:CD3

dimers		R-HSA-9664275 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:SYKArrowR-HSA-9664273 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:SYKR-HSA-9664261 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKArrowR-HSA-9664261 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKArrowR-HSA-9664271 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKR-HSA-9664270 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersArrowR-HSA-9664275 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersR-HSA-9664273 (Reactome)
IgG:Lma amastigote surfaceArrowR-HSA-9664285 (Reactome)
IgG:Lma antigensR-HSA-9664268 (Reactome)
IgGR-HSA-9664285 (Reactome)
IgGR-HSA-9664397 (Reactome)
L-GluArrowR-HSA-266046 (Reactome)
LPG1G2R-HSA-9664397 (Reactome)
LTC4:CyslTR1,2ArrowR-HSA-9664306 (Reactome)
LTC4R-HSA-266046 (Reactome)
LTC4R-HSA-9664306 (Reactome)
LTD4ArrowR-HSA-266046 (Reactome)
LTD4R-HSA-266012 (Reactome)
LTE4ArrowR-HSA-266012 (Reactome)
Ligand:GPCR

complexes that activate Gs:Heterotrimeric G-protein Gs

(inactive)		mim-catalysisR-HSA-9660824 (Reactome)
Lma amastigote surfaceR-HSA-9664285 (Reactome)
MYH9R-HSA-9663426 (Reactome)
PI(3,4,5)P3ArrowR-HSA-9664271 (Reactome)
PI(3,4,5)P3R-HSA-9664278 (Reactome)
PI(4,5)P2R-HSA-202407 (Reactome)
PKA catalytic subunitArrowR-HSA-111925 (Reactome)
PKA catalytic subunitR-HSA-111924 (Reactome)
PKA tetramer:4xcAMPArrowR-HSA-8951727 (Reactome)
PKA tetramer:4xcAMPR-HSA-111925 (Reactome)
PKA tetramerR-HSA-8951727 (Reactome)
PLC gamma1,2R-HSA-9664270 (Reactome)
PLK2, MAPK14mim-catalysisR-HSA-9662823 (Reactome)
PPiArrowR-HSA-111930 (Reactome)
PPiArrowR-HSA-392129 (Reactome)
PRKACA,(PRKACB,PRKACG,PRKX)mim-catalysisR-HSA-111919 (Reactome)
Protein Kinase A, catalytic subunitsArrowR-HSA-111924 (Reactome)
R-HSA-111919 (Reactome) Protein kinase A (PKA) has two regulatory subunits and two catalytic subunits which are held together to form the holoenzyme and is activated upon binding of cAMP to the regulatory subunits. Once cAMP binds the regulatory subunits, the catalytic subunits are released to carry out phosphorylation of CREB1 at serine residue S133. Only the PKA catalytic subunit alpha, PRKACA, was directly demonstrated to phosphorylate CREB1 at S133, using recombinant mouse and rat proteins, respectively (Gonzalez and Montminy 1989). PKA catalytic subunits beta and gamma (PRKACB and PRKACG) are candidate CREB1 kinases based on indirect evidence and sequence similarity (Nagakura et al. 2002, Liang et al. 2007, James et al. 2009). PRKX is the catalytic subunit of the cAMP dependent protein kinase X, which shares the regulatory subunits and functional properties with the PKA. PRKX is highly expressed in the mouse fetal brain (Li et al. 2005) and is implicated in CREB1 phosphorylation through indirect evidence (Di Pasquale and Stacey 1998, Li et al. 2002).
R-HSA-111924 (Reactome) When cAMP level rises, the PKA catalytic subunit (C subunit) released from the holoenzyme enters the nucleus by passive diffusion whereas termination of signaling to the nucleus involves an active mechanism. In the nucleus, the C subunit binds to the heat-stable protein kinase inhibitor (PKI), and this binding not only inactivates the C subunit but also by conformational change unveils a nuclear export signal in PKI which leads to export of the C-PKI complex from the nucleus.
R-HSA-111925 (Reactome) The protein kinase A (PKA) regulatory subunit isoforms differ in their tissue specificity and functional characteristics. The specific isoform activated in response to glucagon signaling is not known. The PKA kinase is a tetramer of two regulatory and two catalytic subunits. The regulatory subunits block the catalytic subunits. Binding of cAMP to the regulatory subunit triggers dissociation of the tetramer into two active dimers made up of a regulatory and a catalytic subunit.
R-HSA-111930 (Reactome) Adenylate cyclase is responsive to calcium and calmodulin and produces cAMP. One important physiological role for Calmodulin is the regulation of adenylylcyclases. Four of the ten known adenylylcyclases are calcium sensitive, in particular type 8 (AC8).
R-HSA-163617 (Reactome) G(s)-alpha:GTP binds to inactive adenylate cyclase, causing a conformational transition in adenylate cyclase exposing the catalytic site and activating it.
R-HSA-169680 (Reactome) The IP3 receptor (IP3R) is an IP3-gated calcium channel. It is a large, homotetrameric protein, similar to other calcium channel proteins such as ryanodine. The four subunits form a 'four-leafed clover' structure arranged around the central calcium channel. Binding of ligands such as IP3 results in conformational changes in the receptor's structure that leads to channel opening.
R-HSA-169683 (Reactome) IP3 promotes the release of intracellular calcium.
R-HSA-202407 (Reactome) On recruitment to plasma membrane PLC-gamma1 then hydrolyses PIP2 producing two second messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 induces a transient increase in intracellular free Ca++, while DAG is a direct activator of protein kinase C (PKC theta). These process have been implicated in many cellular physiological functions like cell proliferation, cell growth and differentiation.
R-HSA-266012 (Reactome) Another outer surface membrane-bound, homodimeric enzyme, dipeptidase, existing in two forms DPEP1 (Adachi et al. 1989) and DPEP2 (Lee et al. 1983, Raulf et al. 1987), further hydrolyses leukotriene D4 (LTD4) to leukotriene E4 (LTE4), cleaving a glycine residue in the process.
R-HSA-266046 (Reactome) The reversible conversion of leukotriene C4 (LTC4) to leukotriene D4 (LTD4) is catalysed by gamma-glutamyl transferases 1 (GGT1) and 5 (GGT5). GGTs are present on the outer surface of plasma membranes and are a heterodimer of a heavy and a light chain. Its action involves the hydrolysis of the gamma-glutamyl peptide bond of glutathione and glutathione conjugates, releasing glutamate. In this example, LTC4 is a glutathione conjugate that is hydrolysed to LTD4 (Anderson et al. 1982, Wickham et al. 2011).
R-HSA-392129 (Reactome) The activation of adenylyl (adenylate) cyclase (AC) results in the production of adenosine-3',5'-monophosphate i.e. cyclic AMP. Humans have 9 genes encoding membrane-associated AC and one encoding a soluble AC. Two of the classes of heterotrimeric G-proteins are named according to their effect on AC; G(s) stimulates all membrane-bound ACs (the s in G(s) denotes AC stimulatory); the G(i) class inhibits some AC isoforms, particularly 5 and 6. Beta-gamma subunits of heterotrimeric G-proteins can also regulate AC. Ca2+/Calmodulin activates some AC isoforms (1, 8 and 3) but is inhibitory to others (5 and 6).
R-HSA-74448 (Reactome) Upon increase in calcium concentration, calmodulin (CaM) is activated by binding to four calcium ions (Crouch and Klee 1980).
R-HSA-8951727 (Reactome) Protein kinase A (PKA) regulatory subunit isoforms differ in their tissue specificity and functional characteristics. The isoform activated in response to glucagon signaling is not known.

PKA kinase is a tetramer of two regulatory and two catalytic subunits. The regulatory subunits block the activity of the catalytic subunits.

cAMP binds the regulatory subunits, which leads to dissociation of the tetramer into two active dimers made up of a regulatory and a catalytic subunit.
R-HSA-9660819 (Reactome) The classical view of G-protein signalling is that the G-protein alpha subunit dissociates from the beta:gamma dimer. Activated G alpha (s) and the beta:gamma dimer then participate in separate signaling cascades. Although G protein dissociation has been contested (e.g. Bassi et al. 1996), recent in vivo experiments have demonstrated that dissociation does occur, though possibly not to completion (Lambert 2008).
R-HSA-9660824 (Reactome) The liganded receptor undergoes a conformational change, generating a signal that is propagated in a manner that is not completely understood to the the G-protein. This stimulates the exchange of GDP for GTP in the G-protein alpha subunit, activating the G-protein. This event is negatively regulated by some Activators of G protein signaling (AGS) proteins, a class of proteins identified in yeast functional screens for proteins able to activate G protein signaling in the absence of a G protein–coupled receptor (GPCR) (Cismowski et al. 1999, Takesono et al. 1999). AGS proteins contain G protein regulatory (GPR) motifs (also referred to as the GoLoco motif) that bind and stabilize the Galpha subunit in its GDP-bound conformation (Mochizuki et al. 1996, Peterson et al. 2000, Cao et al. 2004, Blumer & Lanier 2014). Some RGS proteins similarly bind to Galpha preventing the exchange of GDP for GTP (Soundararajan et al. 2008).
R-HSA-9660828 (Reactome) The role of the guanine nucleotide-binding protein G alpha-s subunit (G alpha-s) (Kozasa T et al, 1988) is to activate adenylate cyclase, which, in turn, produces cAMP, which, in turn, activates cAMP-dependent protein kinase.
R-HSA-9660829 (Reactome) Adenosine receptors A2a and A2b (ADORA2A and ADORA2B) bind extracellular adenosine (Ado-Rib) and are believed to play a role in regulating myocardial oxygen consumption and coronary blood flow (Peterfreund 1996). The A2A receptor is responsible for regulating myocardial blood flow by vasodilation of the coronary arteries, which increases blood flow to the myocardium, but may lead to hypotension. Just as in A1 receptors, this normally serves as a protective mechanism. A2B receptor work (Pierce KD et al, 1992) has lagged behind research in the other adenosine receptors.
Both ADORA receptors mediate their actions by coupling with the G protein alpha s subunit which activates adenylyl cyclase and increases intracellular cAMP concentrations. In surfactant physiology, the receptor:adenosine complex positively regulates surfactant export from lamellar bodies. (Cooper JA et al, 1995; Linden J et al, 1999). Adenosine deaminase (CECR1, ADA2) degrades extracellular adenosine (Ade-Rib), reducing or neutralising the positive regulatory effect of adenosine in surfactant export.
R-HSA-9662708 (Reactome) The IL-6 promoter contains several transcription factor-responsive elements (Luo and Zheng 2016). CREB, a classical cAMP-inducible CRE-binding factor interacts with a region of the IL-6 promoter that is known as CRE-like sequence (Dendorfer et al. 1994). Moreover, IL-6 is a pleiotropic cytokine produced by a wide variety of cells including macrophages, T cells, B cells, fibroblasts, and endothelial cells (Yang et al. 2014).
R-HSA-9662710 (Reactome) The gene for IL-6 is located at chromosome 7 whose unit transcription consists of 5 exons and 4 introns. The promoter region contains several transcription start sites with response elements for nuclear factor (NF)-κB, enhancer-binding protein beta (C/EPBβ; formerly NF-IL6), activator protein (AP)-1 (Burger 2013) and CREB transcription factor (Dendorfer et al. 1994). The protein form of human IL-6 is a glycoprotein composed of 184 amino acids with a molecular weight of 21-28 kDa, depending on its degree of glycosylation. It has a 4-helix bundle structure made up of 4 long α-helices arranged in an up-up-down-down topology (Burger 2013).
R-HSA-9662747 (Reactome) In mice, inactive rhomboid protein 2 (iRHOM2) has been shown to be required for disintegrin and metalloproteinase domain-containing protein 17's (ADAM17) exit from the ER (Cavadas et al. 2017), through the trans-Golgi network and on to the plasma membrane (Adrain et al. 2012, McIlwain et al. 2012, Issuree et al. 2013, Cavadas et al. 2017).
R-HSA-9662773 (Reactome) A crystallography study revealed that disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) requires Zinc as a cofactor to function properly (Maskos et al. 1998).
R-HSA-9662781 (Reactome) The CD163 gene encodes scavenger receptor cysteine-rich type 1 protein M130 (CD163) which functions at the plasma membrane of macrophages (Etzerodt & Moestrup 2013). Glucocorticoid, interleukin (IL)-6 and IL-10 are some of the most potent stimulators of CD163 expression (Petra Högger et al. 1998, P Högger et al. 1998, Van den Heuvel et al. 1999, Buechler et al. 2000 & Sulahian et al. 2000, ). For simplicity, the steps involed in transcription and translation have been omitted.
R-HSA-9662786 (Reactome) Disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) is a type I transmembrane protein that consist of an N-terminal signal sequence followed by a prodomain, a metalloproteinase (catalytic) domain, a disintegrin domain, an EGF-like (cysteine-rich) domain, a single transmembrane domain and a cytoplasmic domain (Scheller et al. 2011, Lambrecht et al. 2018). While ADAM17 is being transported through the trans-Golgi network, FURIN cleaves the prodomain region of ADAM17 releasing the inhibitory part (Milla et al. 1999, Gonzales et al. 2004, Wong et al. 2015) and leaving the catalytically-active form (ADAM17(215-827) (Srour et al. 2003, Endres et al. 2003, Adrain et al. 2012, McIlwain et al. 2012, Wong et al. 2015).
R-HSA-9662818 (Reactome) In mice, inactive rhomboid protein 2 (iRHOM2) has been shown to be required for disintegrin and metalloproteinase domain-containing protein 17's (ADAM17) exit from the ER (Cavadas et al. 2017), through the trans-Golgi network and on to the plasma membrane (Adrain et al. 2012, McIlwain et al. 2012, Issuree et al. 2013, Cavadas et al. 2017).
R-HSA-9662823 (Reactome) The phosphorylation of disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) by PLK2 and MAPKs has been determined by direct and indirect experiments (Müllberg et al. 1993, Schwarz et al. 2014, Fan and Derynck 1999; Gechtman et al. 1999; Díaz-Rodríguez et al. 2002; Fan, Turck, and Derynck 2003 & Xu and Derynck 2010). Specifically, the phosphorylation at residues Thr735 (Díaz-Rodríguez et al. 2002 & Xu and Derynck 2010) and Ser819 is required for ectodomains shedding.
R-HSA-9662837 (Reactome) The scavenger receptor cysteine-rich type 1 (CD163) is a transmembrane macrophage protein which upon cleavage, leads to the release of a soluble form (sCD163, CD163(42-1050)) (Droste, Sorg, and Högger 1999 and Hintz et al. 2002). The inflammation-responsive protease ADAM17 can mediate the cleavage of CD163 to release sCD163 (Etzerodt et al. 2010 & Etzerodt et al. 2014).
R-HSA-9663426 (Reactome) The soluble form of CD163 (sCD163) has been suggested to inhibit activated T-lymphocyte proliferation (P Högger & Sorg 2001) by potentially binding to a non-muscle myosin heavy chain type a (MYH9) (Timmermann et al. 2004, Hou et al. 2019).
R-HSA-9664261 (Reactome) Multiple sites of phosphorylation are known to exist in SYK, which both regulate its activity and also serve as docking sites for other proteins. Some of these sites include Y131 of interdomain A, Y323, Y348, and Y352 of interdomain B, and Y525 and Y526 within the activation loop of the kinase domain and Y630 in the C-terminus (Zhang et al. 2002, Lupher et al. 1998, Furlong et al. 1997). Phosphorylation of these tyrosine residues disrupts autoinhibitory interactions and results in kinase activation even in the absence of phosphorylated ITAM tyrosines (Tsang et al. 2008). SYK is primarily phosphorylated by Src family kinases and this acts as an initiating trigger by generating few molecules of activated SYK which are then involved in major SYK autophosphorylation (Hillal et al. 1997).
R-HSA-9664268 (Reactome) Leishmania amastigotes parasites opsonized by IgG are more susceptible to be phagocytosed through FcγRs. Nevertheless, besides the phagocytosis induction, the interaction IgG-FcγRs has been implicated in the synthesis induction, of several cytokines (Buxbaum 2013; Chu et al. 2010; Thomas and Buxbaum 2008). In particular, Buxbaum et al. in 2008 showed that IgGs bound glycoinositol phospholipids (GIPLs) of L. Mexicana and that IgG:GIPLs induces the synthesis of IL-10 through FcγRIII.
R-HSA-9664270 (Reactome) PLCgamma (PLCG) is recruited to FCGR and the phosphorylated Y342 and Y346 in SYK have been reported to be involved in the interaction of PLCG (Law et al. 1996). PLCG accumulates at the phagocytic cup during FCGR, but the exact role of PLCG in the regulation of phagocytosis is not clear. It may be involved in FCGR signaling by activating PKC through DAG production (Garcia-Garcia & Rosales 2002 )
R-HSA-9664271 (Reactome) Activated PLCG translocates to the plasmamembrane and interacts with the inositol ring of the membrane bound phosphatidylinositol 4,5-bisphosphate (PIP2) with its PH domain. The active enzyme promotes intracelllular signaling by catalysing the hydrolysis of PIP2 to generate the second messengers IP3 and DAG.
R-HSA-9664273 (Reactome) SYK is a tyrosine kinase related to ZAP70 that is expressed in all hematopoietic cells and coimmunoprecipitates with the gamma chain associated with FCGRIIIA in macrophages and with FCERI in mast cells. SYK is very important for FCGR phagocytosis and is recruited to these phosphorylated ITAM residues through its two SRC homology 2 (SH2) domains (Agarwal et al. 1993). When SYK kinase expression is inhibited with antisense oligonucleotides both in vitro and in vivo, phagocytosis and inflammation are abolished (Matsuda et al. 1997). The domain structure of SYK comprises a regulatory region at the N-terminus consisting of a pair of SH2 domains separated by an inter-SH2 linker called interdomain A, an SH2-domain-kinase linker termed interdomain B, and a C-terminal kinase domain (Arias-Palomo et al. 2009). In resting state SYK exists in an auto-inhibited conformation by the interactions between the SH2-SH2 regulatory region and the inter-SH2 linker and the catalytic domain. This interdomain interaction reduces the conformational flexibility required by the kinase domain for catalysis (Arias-Palomo et al. 2007). Changes in the orientation of the SH2 domains could control the disruption of the auto inhibitory interactions and the activation of SYK. These movements could be totally or partially induced by the binding to phosphorylated ITAMs and/or phosphorylation of tyrosine residues in interdomain A or B (Arias-Palomo et al. 2009). Tsang et al. suggested that SYK functions as an OR-gate switch with respect to phosphorylation and ITAM binding, as either one stimulus OR the other is sufficient to cause full activation (Tsang et al. 2008).
R-HSA-9664275 (Reactome) After cross linking, Fc gamma receptors are sequestered to lipid rafts where they are complexed with some of the tyrosine kinases of Src family and undergo phosphorylation on the tyrosine residues contained in conserved ITAM sequences. At least six out of nine members of the Src family kinases (SRC, FYN, FGR, HCK, YES and LYN ) have been identified in the phagocytic cells and are implicated in the initiation of Fc gamma mediated signaling. (Suzuki et al. 2000, Majeed et al. 2001, Kwiatkowska et al. 2003). Some of these kinases have been found associated with specific receptors. In monocytes HCK and LYN have been found associated with FCGRI (Durden et al. 1995), whereas only HCK with FCGRIIA (Ghazizadeh et al. 1994) while FGR in neutrophils (Hamada et al. 1993) and LCK in NK cells with FCGRIIIA (Pignata et al. 1993)
The implication of Src kinases in phosphorylation was first supported by pharmacological findings that herbimycin A, a tyrosine kinase inhibitor relatively specific for Src-family kinases, potently suppressed Fc receptor mediated functions (Greenberg et al. 1993, Suzuki et al. 2000). However, their particular involvement in phagocytosis remains unclear, as targeted disruption of single or multiple Src family genes did not result in significant alterations in phagocytosis (Hunter et al. 1993, Fitzer Attas et al. 2000, Suzuki et al. 2000). HCK, FGR and LYN triple-deficient (-/-) macrophages have shown significant delays in FCGR mediated phagocytosis, but these deficiencies do not completly disrupt the process (Fitzer Attas et al. 2000).
Tyrosine residues Y288 and Y304 (Y282 and Y298 according to the literature reference, it is 6 residues shorter compared to uniprot entry due to an alternate initiation codon usage), within ITAM sequence in the cytoplasmic domain of FCGRIIA are the key target sites that are phosphorylated by Src family kinases (Mitchell et al, 1994). In case of FCGRIA and FCGRIIIA the specific tyrosine residues within ITAMs of the associated gamma/zeta chains are phosphorylated by activated Src family kinases (SFKs) (Park et al. 1993).
R-HSA-9664278 (Reactome) PLCG is tyrosine phosphorylated by either SYK or Src kinases on three tyrosine residues and this phosphorylation enhances the activity of PLCG. Although maximal activation requires binding of PLCG to PIP3 with its plecstrin homology (PH) domain.
R-HSA-9664285 (Reactome) The internalization of Leishmania amastigotes by macrophages is thought to be mediated mainly through opsonization with immunoglobulins (Igs) which bind Fc gamma receptors (FCGRs), stimulating their uptake (Morehead et al 2002 & Padigel et al. 2005). Glycoinositol phospholipids (GIPLs) are the most abundant glycolipids on the surface of the amastigote form of Leishmania parasites and Buxbaum and colleagues showed that IgG1 in mice binds GIPL molecules on the amastigote stage of L. mexicana to subsequently induce phagocytosis through FCGRs (Buxbaum 2013).
R-HSA-9664306 (Reactome) The cysteinyl-leukotrienes (cys-LTs) are potent smooth muscle contractile agents mediating bronchoconstriction. Examples are LTC4, LTD4 and LTE4. There are two human cys-LT receptors, 1 (Lynch KR et al, 1999) and 2 (Heise CE et al, 2000). They mediate their effects via coupling to the G protein alpha q/11 subunit (Sarau HM et al, 1999). However, signalling downstream LTC4-cysLTR binding has been associated with the production of IL4, independent of the GPCR associated heterotrimeric protein Gq (Bandeira Melo et al. 2002).
R-HSA-9664332 (Reactome) The IL-10 promoter contains several transcription factor-responsive elements. (Asadullah et al 2003). In macrophages, the major source of IL-10, several receptor-mediated cytokine transcription end up in the activation of IL10 transcription factors, such as CREB (Platzer et al. 1995, Kelly et al 2010 & Sanin et al 2015)
R-HSA-9664346 (Reactome) The Interleukin 10 (IL10) gene is located at chromosome 1q31-32. It encodes for a protein with the same name that acts as a pleiotropic cytokine expressed primarily by monocytes and to a smaller degree by lymphocytes. IL10 down-regulates the expression of Th1 cytokines, MHC class II and costimulatory molecules on macrophages (Eskdale et al. 1997).
R-HSA-9664397 (Reactome) The internalization of Leishmania amastigotes by macrophages is thought to be mediated mainly through opsonization with immunoglobulins (Igs) which bind FcγRs, stimulating the uptake (Morehead et al 2002 & Padigel et al. 2005). Glycoinositol phospholipids (GIPLs) are the most abundant glycolipids on the surface of the amastigote form of Leishmania parasites and Buxbaum and colleagues showed that IgG1 in mice, binds the GIPL molecules on the amastigote stage of L. mexicana to subsequently induced the phagocytosis through FcγRs (Buxbaum 2013).
R-HSA-9665525 (Reactome) Solube CD163 (sCD163) is taken up by T-cells from the circulation by an unknown mechanism (Timmermann et al. 2004).
SYKR-HSA-9664273 (Reactome)
Src family kinases (SFKs)mim-catalysisR-HSA-9664261 (Reactome)
Src family kinases (SFKs)mim-catalysisR-HSA-9664275 (Reactome)
Zn2+R-HSA-9662773 (Reactome)
cAMP:PKA regulatory subunitArrowR-HSA-111925 (Reactome)
cAMPArrowR-HSA-111930 (Reactome)
cAMPArrowR-HSA-392129 (Reactome)
cAMPR-HSA-8951727 (Reactome)
clustered IgG-Ag:p-FCGRs:p-6Y-SYK:PLCGmim-catalysisR-HSA-9664278 (Reactome)
iRHOM2mim-catalysisR-HSA-9662747 (Reactome)
iRHOM2mim-catalysisR-HSA-9662818 (Reactome)
p-PLCGArrowR-HSA-9664271 (Reactome)
p-PLCGmim-catalysisR-HSA-202407 (Reactome)
p-S,T-ADAM17(215-827):Zn2+ArrowR-HSA-9662823 (Reactome)
p-S,T-ADAM17(215-827):Zn2+mim-catalysisR-HSA-9662837 (Reactome)
p-S133-CREB1:IL10 geneArrowR-HSA-9664332 (Reactome)
p-S133-CREB1:IL10 geneArrowR-HSA-9664346 (Reactome)
p-S133-CREB1:IL6 geneArrowR-HSA-9662708 (Reactome)
p-S133-CREB1:IL6 geneArrowR-HSA-9662710 (Reactome)
p-S133-CREB1ArrowR-HSA-111919 (Reactome)
p-S133-CREB1R-HSA-9662708 (Reactome)
p-S133-CREB1R-HSA-9664332 (Reactome)
sCD163:MYH9ArrowR-HSA-9663426 (Reactome)
sCD163ArrowR-HSA-9662837 (Reactome)
sCD163ArrowR-HSA-9665525 (Reactome)
sCD163R-HSA-9663426 (Reactome)
sCD163R-HSA-9665525 (Reactome)
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP4993"
Personal tools